Par value per share, $0.01; shares issued, 386 million as of December 31, 2019 and 381 million as of December 31, 2018; authorized shares; 600 million.
Includes restricted cash of $26 million reported in Other noncurrent assets and $23 million reported in Long-term investments as of December 31, 2019.
0001739940 2019-01-01 2019-12-31 0001739940 2018-01-01 2018-12-31 0001739940 2017-01-01 2017-12-31 0001739940 2018-12-31 0001739940 2019-12-31 0001739940 us-gaap:TreasuryStockMember 2018-01-01 2018-12-31 0001739940 us-gaap:ParentMember 2018-01-01 2018-12-31 0001739940 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001739940 us-gaap:ParentMember 2019-01-01 2019-12-31 0001739940 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001739940 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001739940 us-gaap:TreasuryStockMember 2017-12-31 0001739940 us-gaap:ParentMember 2017-12-31 0001739940 us-gaap:NoncontrollingInterestMember 2017-12-31 0001739940 2017-12-31 0001739940 us-gaap:CommonStockMember 2018-12-31 0001739940 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001739940 us-gaap:TreasuryStockMember 2018-12-31 0001739940 us-gaap:ParentMember 2018-12-31 0001739940 us-gaap:NoncontrollingInterestMember 2018-12-31 0001739940 us-gaap:CommonStockMember 2019-12-31 0001739940 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001739940 us-gaap:TreasuryStockMember 2019-12-31 0001739940 us-gaap:ParentMember 2019-12-31 0001739940 us-gaap:NoncontrollingInterestMember 2019-12-31 0001739940 us-gaap:CommonStockMember 2017-12-31 0001739940 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001739940 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001739940 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001739940 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001739940 us-gaap:RetainedEarningsMember 2018-12-31 0001739940 us-gaap:RetainedEarningsMember 2017-12-31 0001739940 us-gaap:RetainedEarningsMember 2019-12-31 0001739940 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001739940 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001739940 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-12-31 0001739940 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001739940 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-12-31 0001739940 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2019-01-01 2019-12-31 0001739940 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2019-01-01 2019-12-31 0001739940 srt:MinimumMember us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2019-01-01 2019-12-31 0001739940 us-gaap:SoftwareDevelopmentMember srt:MaximumMember 2019-01-01 2019-12-31 0001739940 us-gaap:PropertyPlantAndEquipmentOtherTypesMember srt:MaximumMember 2019-01-01 2019-12-31 0001739940 us-gaap:BuildingAndBuildingImprovementsMember srt:MaximumMember 2019-01-01 2019-12-31 0001739940 srt:MinimumMember 2019-01-01 2019-12-31 0001739940 srt:MaximumMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember 2019-12-31 0001739940 ci:IntegratedMedicalMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:CompletionFactorsMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicalCostTrendMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicalCostTrendMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:NoncatastrophicEventOtherMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:CompletionFactorsMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:NoncatastrophicEventOtherMember 2019-01-01 2019-12-31 0001739940 ci:InternationalMarketsMember 2018-12-31 0001739940 ci:InternationalMarketsGroupDisabilityAndLifeMember 2016-12-31 0001739940 ci:InternationalMarketsGroupDisabilityAndLifeMember 2017-01-01 2017-12-31 0001739940 ci:InternationalMarketsGroupDisabilityAndLifeMember 2018-01-01 2018-12-31 0001739940 ci:InternationalMarketsGroupDisabilityAndLifeMember 2019-01-01 2019-12-31 0001739940 ci:InternationalMarketsGroupDisabilityAndLifeMember 2018-12-31 0001739940 ci:InternationalMarketsGroupDisabilityAndLifeMember 2017-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember 2019-01-01 2019-12-31 0001739940 ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember ci:IndividualLifeInsuranceAndAnnuityMember 2018-12-31 0001739940 ci:PrudentialRetirementInsuranceAndAnnuityCompanyMember ci:RetirementBenefitsMember 2018-12-31 0001739940 ci:GreatAmericanLifeInsuranceCompanyMember ci:LifeInsuranceAndAnnuityAcquiredFromGreatAmericanMember 2018-12-31 0001739940 ci:OtherRetrocessionairesMember ci:OtherRunoffMember 2018-12-31 0001739940 ci:OtherRetrocessionairesMember ci:OtherRunoffMember us-gaap:ReinsuranceRecoverableMember us-gaap:CededCreditRiskSecuredMember 2019-01-01 2019-12-31 0001739940 ci:GreatAmericanLifeInsuranceCompanyMember ci:LifeInsuranceAndAnnuityAcquiredFromGreatAmericanMember us-gaap:ReinsuranceRecoverableMember us-gaap:CededCreditRiskSecuredMember 2019-01-01 2019-12-31 0001739940 ci:PrudentialRetirementInsuranceAndAnnuityCompanyMember ci:RetirementBenefitsMember us-gaap:ReinsuranceRecoverableMember us-gaap:CededCreditRiskSecuredMember 2019-01-01 2019-12-31 0001739940 us-gaap:ReinsuranceRecoverableMember us-gaap:CededCreditRiskSecuredMember ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember ci:GuaranteedMinimumDeathBenefitsMember 2019-01-01 2019-12-31 0001739940 ci:AcquisitionDispositionRunoffActivitiesMember 2018-12-31 0001739940 ci:ShortDurationContractsMember 2019-01-01 2019-12-31 0001739940 ci:ShortDurationContractsMember 2018-01-01 2018-12-31 0001739940 ci:ShortDurationContractsMember 2017-01-01 2017-12-31 0001739940 ci:LongDurationContractsMember 2019-01-01 2019-12-31 0001739940 ci:LongDurationContractsMember 2018-01-01 2018-12-31 0001739940 ci:LongDurationContractsMember 2017-01-01 2017-12-31 0001739940 ci:LongDurationContractsMember ci:IndividualLifeInsuranceAndAnnuityBusinessSoldMember 2017-01-01 2017-12-31 0001739940 ci:LongDurationContractsMember ci:IndividualLifeInsuranceAndAnnuityBusinessSoldMember 2018-01-01 2018-12-31 0001739940 ci:LongDurationContractsMember ci:IndividualLifeInsuranceAndAnnuityBusinessSoldMember 2019-01-01 2019-12-31 0001739940 ci:LongDurationContractsMember ci:OtherSubsegmentsMember 2017-01-01 2017-12-31 0001739940 ci:LongDurationContractsMember ci:OtherSubsegmentsMember 2018-01-01 2018-12-31 0001739940 ci:LongDurationContractsMember ci:OtherSubsegmentsMember 2019-01-01 2019-12-31 0001739940 ci:IndividualLifeInsuranceAndAnnuityBusinessSoldMember 2017-01-01 2017-12-31 0001739940 ci:IndividualLifeInsuranceAndAnnuityBusinessSoldMember 2018-01-01 2018-12-31 0001739940 ci:IndividualLifeInsuranceAndAnnuityBusinessSoldMember 2019-01-01 2019-12-31 0001739940 ci:OtherSubsegmentsMember 2017-01-01 2017-12-31 0001739940 ci:OtherSubsegmentsMember 2018-01-01 2018-12-31 0001739940 ci:OtherSubsegmentsMember 2019-01-01 2019-12-31 0001739940 us-gaap:VariableAnnuityMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-12-31 0001739940 us-gaap:VariableAnnuityMember us-gaap:GuaranteedMinimumDeathBenefitMember 2018-12-31 0001739940 us-gaap:VariableAnnuityMember us-gaap:GuaranteedMinimumDeathBenefitMember 2019-01-01 2019-12-31 0001739940 us-gaap:VariableAnnuityMember us-gaap:GuaranteedMinimumDeathBenefitMember 2018-01-01 2018-12-31 0001739940 ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember us-gaap:GuaranteedMinimumIncomeBenefitMember 2019-12-31 0001739940 ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember us-gaap:GuaranteedMinimumIncomeBenefitMember 2018-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember ci:SunLifeAssuranceCompanyOfCanadaMember 2019-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember ci:SunLifeAssuranceCompanyOfCanadaMember 2018-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember ci:LibertyMutualInsuranceMember 2019-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember ci:LibertyMutualInsuranceMember 2018-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember 2019-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember 2018-12-31 0001739940 us-gaap:CededCreditRiskSecuredMember ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember us-gaap:GuaranteedMinimumIncomeBenefitMember ci:GuaranteedMinimumIncomeBenefitsAssetsMember 2019-01-01 2019-12-31 0001739940 us-gaap:CededCreditRiskSecuredMember us-gaap:GuaranteedMinimumIncomeBenefitMember ci:LibertyMutualInsuranceMember ci:GuaranteedMinimumIncomeBenefitsAssetsMember 2019-01-01 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember ci:UnobservableInputsDevelopedByCompanyMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member ci:UnobservableInputsDevelopedByCompanyMember ci:CorporateAndGovernmentDebtSecuritiesMember 2018-12-31 0001739940 ci:DebtAndEquitySecuritiesMember 2019-01-01 2019-12-31 0001739940 ci:DebtAndEquitySecuritiesMember 2017-12-31 0001739940 ci:DebtAndEquitySecuritiesMember 2018-01-01 2018-12-31 0001739940 us-gaap:FairValueInputsLevel1Member 2018-12-31 0001739940 us-gaap:FairValueInputsLevel2Member 2018-12-31 0001739940 us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember ci:SeparateAccountAssetsMember srt:PartnershipInterestMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember ci:SeparateAccountAssetsMember us-gaap:RealEstateFundsMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember ci:SeparateAccountAssetsMember us-gaap:HedgeFundsMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember ci:SeparateAccountAssetsMember 2018-12-31 0001739940 ci:SeparateAccountAssetsMember srt:PartnershipInterestMember 2019-12-31 0001739940 ci:SeparateAccountAssetsMember us-gaap:RealEstateFundsMember 2019-12-31 0001739940 ci:SeparateAccountAssetsMember us-gaap:HedgeFundsMember 2019-12-31 0001739940 ci:SeparateAccountAssetsMember 2019-12-31 0001739940 ci:SeparateAccountAssetsMember srt:PartnershipInterestMember 2019-01-01 2019-12-31 0001739940 ci:SeparateAccountAssetsMember us-gaap:RealEstateFundsMember 2019-01-01 2019-12-31 0001739940 ci:SeparateAccountAssetsMember us-gaap:HedgeFundsMember 2019-01-01 2019-12-31 0001739940 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0001739940 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0001739940 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001739940 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0001739940 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0001739940 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember 2019-01-01 2019-12-31 0001739940 us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001739940 us-gaap:USStatesAndPoliticalSubdivisionsMember 2018-12-31 0001739940 us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001739940 us-gaap:RealEstateInvestmentMember 2018-12-31 0001739940 srt:PartnershipInterestMember 2018-12-31 0001739940 us-gaap:OtherLongTermInvestmentsMember 2018-12-31 0001739940 us-gaap:EquitySecuritiesMember 2019-01-01 2019-12-31 0001739940 us-gaap:PolicyLoansMember 2019-01-01 2019-12-31 0001739940 us-gaap:OtherLongTermInvestmentsMember 2019-01-01 2019-12-31 0001739940 ci:CashCashEquivalentsAndShortTermInvestmentsMember 2019-01-01 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember 2018-01-01 2018-12-31 0001739940 us-gaap:EquitySecuritiesMember 2018-01-01 2018-12-31 0001739940 us-gaap:PolicyLoansMember 2018-01-01 2018-12-31 0001739940 us-gaap:OtherLongTermInvestmentsMember 2018-01-01 2018-12-31 0001739940 ci:CashCashEquivalentsAndShortTermInvestmentsMember 2018-01-01 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember 2017-01-01 2017-12-31 0001739940 us-gaap:EquitySecuritiesMember 2017-01-01 2017-12-31 0001739940 us-gaap:PolicyLoansMember 2017-01-01 2017-12-31 0001739940 us-gaap:OtherLongTermInvestmentsMember 2017-01-01 2017-12-31 0001739940 ci:CashCashEquivalentsAndShortTermInvestmentsMember 2017-01-01 2017-12-31 0001739940 us-gaap:MortgagesMember 2019-01-01 2019-12-31 0001739940 us-gaap:MortgagesMember 2018-01-01 2018-12-31 0001739940 us-gaap:MortgagesMember 2017-01-01 2017-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001739940 us-gaap:PerformanceSharesMember 2019-01-01 2019-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2019-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2018-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2016-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2017-12-31 0001739940 ci:RestrictedStockGrantsAndUnitsMember 2019-12-31 0001739940 ci:RestrictedStockGrantsAndUnitsMember 2019-01-01 2019-12-31 0001739940 ci:RestrictedStockGrantsAndUnitsMember 2017-12-31 0001739940 ci:RestrictedStockGrantsAndUnitsMember 2017-01-01 2017-12-31 0001739940 ci:RestrictedStockGrantsAndUnitsMember 2016-12-31 0001739940 ci:RestrictedStockGrantsAndUnitsMember 2018-01-01 2018-12-31 0001739940 ci:RestrictedStockGrantsAndUnitsMember 2018-12-31 0001739940 us-gaap:PerformanceSharesMember 2016-12-31 0001739940 us-gaap:PerformanceSharesMember 2017-01-01 2017-12-31 0001739940 us-gaap:PerformanceSharesMember 2017-12-31 0001739940 us-gaap:PerformanceSharesMember 2018-01-01 2018-12-31 0001739940 us-gaap:PerformanceSharesMember 2018-12-31 0001739940 us-gaap:PerformanceSharesMember 2019-12-31 0001739940 srt:MinimumMember ci:PurchasedSoftwareMember 2019-01-01 2019-12-31 0001739940 srt:MaximumMember ci:PurchasedSoftwareMember 2019-01-01 2019-12-31 0001739940 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-12-31 0001739940 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2019-01-01 2019-12-31 0001739940 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-01-01 2018-12-31 0001739940 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2017-01-01 2017-12-31 0001739940 us-gaap:OtherIntangibleAssetsMember 2019-01-01 2019-12-31 0001739940 us-gaap:OtherIntangibleAssetsMember 2018-01-01 2018-12-31 0001739940 us-gaap:OtherIntangibleAssetsMember 2017-01-01 2017-12-31 0001739940 us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember 2017-01-01 2017-12-31 0001739940 us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember 2019-01-01 2019-12-31 0001739940 us-gaap:InsuranceContractsAcquiredInBusinessCombinationMember 2018-01-01 2018-12-31 0001739940 ci:AssetsHeldUnderCapitalLeasesAndOtherCapitalizedPropertyPlantAndEquipmentMember 2019-01-01 2019-12-31 0001739940 ci:AssetsHeldUnderCapitalLeasesAndOtherCapitalizedPropertyPlantAndEquipmentMember 2017-01-01 2017-12-31 0001739940 ci:AssetsHeldUnderCapitalLeasesAndOtherCapitalizedPropertyPlantAndEquipmentMember 2018-01-01 2018-12-31 0001739940 2016-12-31 0001739940 ci:RetirementAndLifeInsuranceContractsMember us-gaap:FinancialGuaranteeMember 2019-12-31 0001739940 srt:MinimumMember ci:RetirementAndLifeInsuranceContractsMember us-gaap:FinancialGuaranteeMember 2019-01-01 2019-12-31 0001739940 srt:MinimumMember us-gaap:PositiveOutcomeOfLitigationMember 2019-12-31 0001739940 2019-01-01 2019-03-31 0001739940 2019-04-01 2019-06-30 0001739940 2019-07-01 2019-09-30 0001739940 2019-10-01 2019-12-31 0001739940 2018-01-01 2018-03-31 0001739940 2018-04-01 2018-06-30 0001739940 2018-07-01 2018-09-30 0001739940 2018-10-01 2018-12-31 0001739940 srt:ParentCompanyMember 2019-01-01 2019-12-31 0001739940 srt:ParentCompanyMember 2019-12-31 0001739940 us-gaap:AllowanceForLoanAndLeaseLossesMember 2017-01-01 2017-12-31 0001739940 us-gaap:AllowanceForLoanAndLeaseLossesMember 2017-12-31 0001739940 us-gaap:AllowanceForLoanAndLeaseLossesMember 2016-12-31 0001739940 us-gaap:AllowanceForCreditLossMember 2019-01-01 2019-12-31 0001739940 us-gaap:AllowanceForCreditLossMember 2019-12-31 0001739940 us-gaap:AllowanceForCreditLossMember 2018-01-01 2018-12-31 0001739940 us-gaap:AllowanceForCreditLossMember 2018-12-31 0001739940 us-gaap:AllowanceForCreditLossMember 2016-12-31 0001739940 us-gaap:AllowanceForCreditLossMember 2017-01-01 2017-12-31 0001739940 us-gaap:AllowanceForCreditLossMember 2017-12-31 0001739940 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001739940 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-01-01 2017-12-31 0001739940 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-01-01 2018-12-31 0001739940 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-12-31 0001739940 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001739940 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0001739940 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-12-31 0001739940 us-gaap:AllowanceForReinsuranceRecoverableMember 2017-01-01 2017-12-31 0001739940 us-gaap:AllowanceForReinsuranceRecoverableMember 2018-01-01 2018-12-31 0001739940 us-gaap:AllowanceForReinsuranceRecoverableMember 2019-01-01 2019-12-31 0001739940 us-gaap:AllowanceForReinsuranceRecoverableMember 2017-12-31 0001739940 us-gaap:AllowanceForReinsuranceRecoverableMember 2019-12-31 0001739940 us-gaap:AllowanceForReinsuranceRecoverableMember 2018-12-31 0001739940 us-gaap:AllowanceForReinsuranceRecoverableMember 2016-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001739940 us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001739940 us-gaap:ForeignGovernmentDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:MoneyMarketFundsMember 2018-12-31 0001739940 ci:RunoffSettlementAnnuityBusinessMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SwapMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:SwapMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SwapMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SwapMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 ci:LtvLessThan60PercentMember 2018-12-31 0001739940 ci:Ltv60To79PercentMember 2018-12-31 0001739940 us-gaap:Ltv80To100PercentMember 2018-12-31 0001739940 srt:WeightedAverageMember 2018-01-01 2018-12-31 0001739940 ci:LtvLessThan60PercentMember srt:WeightedAverageMember 2018-01-01 2018-12-31 0001739940 ci:Ltv60To79PercentMember srt:WeightedAverageMember 2018-01-01 2018-12-31 0001739940 us-gaap:Ltv80To100PercentMember srt:WeightedAverageMember 2018-01-01 2018-12-31 0001739940 country:US 2019-01-01 2019-12-31 0001739940 country:US 2018-01-01 2018-12-31 0001739940 country:US 2017-01-01 2017-12-31 0001739940 country:KR 2019-01-01 2019-12-31 0001739940 country:KR 2018-01-01 2018-12-31 0001739940 country:KR 2017-01-01 2017-12-31 0001739940 ci:AllOtherCountriesMember 2019-01-01 2019-12-31 0001739940 ci:AllOtherCountriesMember 2018-01-01 2018-12-31 0001739940 ci:AllOtherCountriesMember 2017-01-01 2017-12-31 0001739940 ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember ci:GuaranteedMinimumDeathBenefitsMember 2018-12-31 0001739940 us-gaap:ReinsuranceRecoverableMember srt:MinimumMember ci:OngoingOperationsMember ci:StandardPoorsInvestmentGradeRatingMemberMember 2019-01-01 2019-12-31 0001739940 srt:MaximumMember ci:OngoingOperationsMember 2019-12-31 0001739940 ci:OngoingOperationsMember 2019-12-31 0001739940 ci:NotesDue2020FloatingRateInterestMember 2019-12-31 0001739940 ci:NotesDue2020FloatingRateInterestMember 2018-12-31 0001739940 ci:NotesDue202032InterestMember 2019-12-31 0001739940 ci:NotesDue202032InterestMember 2018-12-31 0001739940 ci:NotesDue2021FloatingRateInterestMember 2019-12-31 0001739940 ci:NotesDue2021FloatingRateInterestMember 2018-12-31 0001739940 ci:NotesDue202134InterestMember 2019-12-31 0001739940 ci:NotesDue202134InterestMember 2018-12-31 0001739940 ci:LoanDue2021FloatingRateInterestMember 2019-12-31 0001739940 ci:LoanDue2021FloatingRateInterestMember 2018-12-31 0001739940 ci:NotesDue2023FloatingRateInterestMember 2019-12-31 0001739940 ci:NotesDue2023FloatingRateInterestMember 2018-12-31 0001739940 ci:NotesDue2023375InterestMember 2019-12-31 0001739940 ci:NotesDue2023375InterestMember 2018-12-31 0001739940 ci:NotesDue20254125InterestMember 2019-12-31 0001739940 ci:NotesDue20254125InterestMember 2018-12-31 0001739940 ci:NotesDue20284375InterestMember 2019-12-31 0001739940 ci:NotesDue20284375InterestMember 2018-12-31 0001739940 ci:NotesDue203848InterestMember 2019-12-31 0001739940 ci:NotesDue203848InterestMember 2018-12-31 0001739940 ci:NotesDue204849InterestMember 2019-12-31 0001739940 ci:NotesDue204849InterestMember 2018-12-31 0001739940 ci:NotesDue20204125InterestMember 2019-12-31 0001739940 ci:NotesDue20204125InterestMember 2018-12-31 0001739940 ci:NotesDue202026InterestMember 2019-12-31 0001739940 ci:NotesDue202026InterestMember 2018-12-31 0001739940 ci:NotesDue2020FloatingRateInterestExpressScriptsMember 2019-12-31 0001739940 ci:NotesDue2020FloatingRateInterestExpressScriptsMember 2018-12-31 0001739940 ci:NotesDue202133InterestMember 2019-12-31 0001739940 ci:NotesDue202133InterestMember 2018-12-31 0001739940 ci:NotesDue2021475InterestMember 2019-12-31 0001739940 ci:NotesDue2021475InterestMember 2018-12-31 0001739940 ci:NotesDue202239InterestMember 2019-12-31 0001739940 ci:NotesDue202239InterestMember 2018-12-31 0001739940 ci:NotesDue2022305InterestMember 2019-12-31 0001739940 ci:NotesDue2022305InterestMember 2018-12-31 0001739940 ci:NotesDue20233InterestMember 2019-12-31 0001739940 ci:NotesDue20233InterestMember 2018-12-31 0001739940 ci:NotesDue202435InterestMember 2019-12-31 0001739940 ci:NotesDue202435InterestMember 2018-12-31 0001739940 ci:NotesDue202645InterestMember 2019-12-31 0001739940 ci:NotesDue202645InterestMember 2018-12-31 0001739940 ci:NotesDue202734InterestMember 2019-12-31 0001739940 ci:NotesDue202734InterestMember 2018-12-31 0001739940 ci:NotesDue20416125InterestMember 2019-12-31 0001739940 ci:NotesDue20416125InterestMember 2018-12-31 0001739940 ci:NotesDue204648InterestMember 2019-12-31 0001739940 ci:NotesDue204648InterestMember 2018-12-31 0001739940 ci:NotesDue20204375InterestMember 2019-12-31 0001739940 ci:NotesDue20205125InterestMember 2019-12-31 0001739940 ci:NotesDue2021637InterestMember 2019-12-31 0001739940 ci:NotesDue202145InterestMember 2019-12-31 0001739940 ci:NotesDue20224InterestMember 2019-12-31 0001739940 ci:NotesDue2023765InterestMember 2019-12-31 0001739940 ci:NotesDue202383InterestMember 2019-12-31 0001739940 ci:NotesDue2025325InterestMember 2019-12-31 0001739940 ci:NotesDue2027305Member 2019-12-31 0001739940 ci:DebenturesDue20277875InterestMember 2019-12-31 0001739940 ci:StepDownNotesDue203383InterestMember 2019-12-31 0001739940 ci:NotesDue2036615InterestMember 2019-12-31 0001739940 ci:NotesDue20415875InterestMember 2019-12-31 0001739940 ci:NotesDue20425375InterestMember 2019-12-31 0001739940 ci:NotesDue20473875Member 2019-12-31 0001739940 ci:NotesDue20204375InterestMember 2018-12-31 0001739940 ci:NotesDue2021637InterestMember 2018-12-31 0001739940 ci:NotesDue202145InterestMember 2018-12-31 0001739940 ci:NotesDue20224InterestMember 2018-12-31 0001739940 ci:NotesDue2023765InterestMember 2018-12-31 0001739940 ci:NotesDue202383InterestMember 2018-12-31 0001739940 ci:NotesDue2025325InterestMember 2018-12-31 0001739940 ci:NotesDue2027305Member 2018-12-31 0001739940 ci:DebenturesDue20277875InterestMember 2018-12-31 0001739940 ci:StepDownNotesDue203383InterestMember 2018-12-31 0001739940 ci:NotesDue2036615InterestMember 2018-12-31 0001739940 ci:NotesDue20415875InterestMember 2018-12-31 0001739940 ci:NotesDue20425375InterestMember 2018-12-31 0001739940 ci:NotesDue20473875Member 2018-12-31 0001739940 us-gaap:ServiceMember 2019-01-01 2019-12-31 0001739940 us-gaap:ServiceMember 2018-01-01 2018-12-31 0001739940 us-gaap:ServiceMember 2017-01-01 2017-12-31 0001739940 us-gaap:ProductMember 2019-01-01 2019-12-31 0001739940 us-gaap:ProductMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember 2018-12-31 0001739940 ci:InternationalMarketsAndGroupDisabilityAndOtherMember 2018-12-31 0001739940 ci:GroupDisabilityAndOtherMember 2018-12-31 0001739940 us-gaap:AllOtherSegmentsMember 2018-12-31 0001739940 ci:GroupDisabilityAndLifeMember 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicalRiskProductsMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:StopLossMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:OtherCommercialMedicalProductsMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicalRiskProductsMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:StopLossMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:OtherCommercialMedicalProductsMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicalRiskProductsMember 2017-01-01 2017-12-31 0001739940 ci:IntegratedMedicalMember ci:StopLossMember 2017-01-01 2017-12-31 0001739940 ci:IntegratedMedicalMember ci:OtherCommercialMedicalProductsMember 2017-01-01 2017-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicareAdvantageMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicarePartDMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:OtherGovernmentProductsMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicareAdvantageMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicarePartDMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:OtherGovernmentProductsMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicareAdvantageMember 2017-01-01 2017-12-31 0001739940 ci:IntegratedMedicalMember ci:MedicarePartDMember 2017-01-01 2017-12-31 0001739940 ci:IntegratedMedicalMember ci:OtherGovernmentProductsMember 2017-01-01 2017-12-31 0001739940 ci:HomeDeliveryAndSpecialtyMember 2019-01-01 2019-12-31 0001739940 ci:HomeDeliveryAndSpecialtyMember 2018-01-01 2018-12-31 0001739940 ci:HomeDeliveryAndSpecialtyMember 2017-01-01 2017-12-31 0001739940 ci:NetworkPharmacyMember 2019-01-01 2019-12-31 0001739940 ci:NetworkPharmacyMember 2018-01-01 2018-12-31 0001739940 ci:NetworkPharmacyMember 2017-01-01 2017-12-31 0001739940 ci:OtherPharmacyMember 2019-01-01 2019-12-31 0001739940 ci:OtherPharmacyMember 2018-01-01 2018-12-31 0001739940 ci:OtherPharmacyMember 2017-01-01 2017-12-31 0001739940 ci:InternationalMarketsMember 2019-01-01 2019-12-31 0001739940 ci:InternationalMarketsMember 2018-01-01 2018-12-31 0001739940 ci:InternationalMarketsMember 2017-01-01 2017-12-31 0001739940 ci:IntegratedMedicalMember 2017-01-01 2017-12-31 0001739940 ci:OldCignaPreAcquisitionMember 2016-12-31 0001739940 ci:GroupDisabilityAndOtherMember ci:DisabilityLifeAccidentMember 2019-01-01 2019-12-31 0001739940 ci:GroupDisabilityAndOtherMember ci:DisabilityLifeAccidentMember 2018-01-01 2018-12-31 0001739940 ci:GroupDisabilityAndOtherMember ci:DisabilityLifeAccidentMember 2017-01-01 2017-12-31 0001739940 ci:OldCignaPreAcquisitionMember 2018-12-31 0001739940 ci:OldCignaPreAcquisitionMember 2017-12-31 0001739940 ci:GroupDisabilityAndOtherMember us-gaap:ServiceOtherMember 2019-01-01 2019-12-31 0001739940 ci:GroupDisabilityAndOtherMember us-gaap:ServiceOtherMember 2018-01-01 2018-12-31 0001739940 ci:GroupDisabilityAndOtherMember us-gaap:ServiceOtherMember 2017-01-01 2017-12-31 0001739940 ci:IntegratedMedicalMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001739940 us-gaap:OperatingSegmentsMember ci:HealthServicesMember 2019-01-01 2019-12-31 0001739940 ci:InternationalMarketsMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001739940 ci:GroupDisabilityAndOtherMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-12-31 0001739940 ci:OldCignaPreAcquisitionMember 2017-01-01 2017-12-31 0001739940 ci:OldCignaPreAcquisitionMember 2018-01-01 2018-12-20 0001739940 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0001739940 ci:CorporateAndEliminationsMember 2019-01-01 2019-12-31 0001739940 ci:CorporateAndEliminationsMember 2018-01-01 2018-12-31 0001739940 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0001739940 us-gaap:OperatingSegmentsMember ci:HealthServicesMember 2018-01-01 2018-12-31 0001739940 ci:InternationalMarketsMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0001739940 ci:GroupDisabilityAndOtherMember us-gaap:OperatingSegmentsMember 2018-01-01 2018-12-31 0001739940 ci:HealthServicesMember 2019-01-01 2019-12-31 0001739940 ci:GroupDisabilityAndOtherMember 2019-01-01 2019-12-31 0001739940 ci:IntegratedMedicalMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0001739940 ci:HealthServicesMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0001739940 ci:InternationalMarketsMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0001739940 ci:GroupDisabilityAndOtherMember us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0001739940 us-gaap:IntersegmentEliminationMember 2019-01-01 2019-12-31 0001739940 ci:HealthServicesMember 2018-01-01 2018-12-31 0001739940 ci:GroupDisabilityAndOtherMember 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0001739940 ci:HealthServicesMember us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0001739940 ci:InternationalMarketsMember us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0001739940 ci:GroupDisabilityAndOtherMember us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0001739940 us-gaap:IntersegmentEliminationMember 2018-01-01 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember 2018-12-31 0001739940 us-gaap:EquitySecuritiesMember 2018-12-31 0001739940 us-gaap:MortgagesMember 2018-12-31 0001739940 us-gaap:PolicyLoansMember 2018-12-31 0001739940 us-gaap:ShortTermInvestmentsMember 2018-12-31 0001739940 us-gaap:OtherLongTermInvestmentsMember 2018-12-31 0001739940 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember us-gaap:CurrencySwapMember 2018-12-31 0001739940 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2018-12-31 0001739940 us-gaap:NondesignatedMember us-gaap:ForwardContractsMember 2018-12-31 0001739940 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember 2019-01-01 2019-12-31 0001739940 ci:OtherInvestmentMember 2019-01-01 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember 2018-01-01 2018-12-31 0001739940 ci:OtherInvestmentMember 2018-01-01 2018-12-31 0001739940 us-gaap:InsuranceRelatedAssessmentsMember 2019-01-01 2019-12-31 0001739940 us-gaap:PendingLitigationMember ci:PricingConcessionsThroughRemainingContractTermMember ci:ExpressScriptsLitigationWithAnthemMember 2019-01-01 2019-12-31 0001739940 us-gaap:PendingLitigationMember ci:ExpressScriptsLitigationWithAnthemMember ci:PricingConcessionsAfterRemainingTermOfAgreementMember 2019-01-01 2019-12-31 0001739940 us-gaap:PendingLitigationMember ci:ExpressScriptsLitigationWithAnthemMember ci:DamagesForServiceIssuesMember 2019-01-01 2019-12-31 0001739940 ci:HealthServicesMember 2019-12-31 0001739940 ci:InternationalMarketsMember 2019-12-31 0001739940 us-gaap:RealEstateInvestmentMember 2019-12-31 0001739940 srt:PartnershipInterestMember 2019-12-31 0001739940 us-gaap:OtherLongTermInvestmentsMember 2019-12-31 0001739940 srt:ParentCompanyMember 2018-12-20 0001739940 us-gaap:CustomerRelationshipsMember 2019-12-31 0001739940 us-gaap:OtherIntangibleAssetsMember 2019-12-31 0001739940 us-gaap:CustomerRelationshipsMember 2018-12-31 0001739940 us-gaap:OtherIntangibleAssetsMember 2018-12-31 0001739940 us-gaap:ParentMember 2018-01-01 0001739940 2018-01-01 0001739940 ci:DebtAndEquitySecuritiesMember 2018-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-31 0001739940 us-gaap:RetainedEarningsMember 2019-01-01 0001739940 us-gaap:ParentMember 2019-01-01 0001739940 2019-01-01 0001739940 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001739940 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0001739940 us-gaap:RetainedEarningsMember 2018-01-01 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember srt:ScenarioPreviouslyReportedMember 2018-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember srt:ScenarioPreviouslyReportedMember 2017-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201802Member 2018-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201601Member 2018-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201712Member 2018-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201802Member 2017-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201601Member 2017-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201712Member 2017-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001739940 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001739940 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001739940 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001739940 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001739940 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001739940 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0001739940 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2019-01-01 2019-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2018-01-01 2018-12-31 0001739940 ci:AccumulatedDefinedBenefitPlansAdjustmentSettlementMember 2019-01-01 2019-12-31 0001739940 ci:AccumulatedDefinedBenefitPlansAdjustmentSettlementMember 2018-01-01 2018-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-12-31 0001739940 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001739940 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001739940 ci:DebtAndEquitySecuritiesMember us-gaap:AccountingStandardsUpdate201601Member 2018-01-01 2018-12-31 0001739940 ci:IntegratedMedicalMember 2017-12-31 0001739940 us-gaap:EquitySecuritiesMember 2018-01-01 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:InvestmentGradeMember 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:InvestmentGradeMember ci:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsMember 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:InvestmentGradeMember ci:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerMember 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:BelowInvestmentGradeMember 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:BelowInvestmentGradeMember ci:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsMember 2018-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:BelowInvestmentGradeMember ci:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerMember 2018-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember us-gaap:VariableAnnuityMember 2019-01-01 2019-12-31 0001739940 ci:SeniorNotes0225Member 2019-12-31 0001739940 ci:SeniorNotes0725Member 2019-12-31 0001739940 ci:SeniorNotes0225Member 2018-12-31 0001739940 ci:SeniorNotes0725Member 2018-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001739940 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001739940 us-gaap:CommercialPaperMember 2019-12-31 0001739940 ci:AmaraCashBalancePensionPlanLitigationMember 2019-01-01 2019-12-31 0001739940 ci:SeparateAccountAssetsMember srt:MinimumMember us-gaap:RealEstateFundsMember 2019-01-01 2019-12-31 0001739940 ci:SeparateAccountAssetsMember srt:MaximumMember us-gaap:RealEstateFundsMember 2019-01-01 2019-12-31 0001739940 ci:SeparateAccountAssetsMember srt:MinimumMember us-gaap:HedgeFundsMember 2019-01-01 2019-12-31 0001739940 ci:SeparateAccountAssetsMember srt:MaximumMember us-gaap:HedgeFundsMember 2019-01-01 2019-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember 2019-01-01 2019-12-31 0001739940 ci:NotesDue20205125InterestMember 2018-12-31 0001739940 ci:OtherRetrocessionairesMember ci:IntegratedMedicalInternationalMarketsGroupDisabilityColiMember 2018-12-31 0001739940 ci:OtherRetrocessionairesMember ci:OngoingOperationsMember 2018-12-31 0001739940 ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember us-gaap:VariableAnnuityMember 2019-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember 2018-01-01 2018-12-31 0001739940 ci:SecurityAndRealEstateLimitedPartnershipsMember 2019-12-31 0001739940 ci:InvestmentEntitiesMember 2019-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001739940 srt:MaximumMember 2019-12-31 0001739940 us-gaap:IndemnificationGuaranteeMember 2019-12-31 0001739940 us-gaap:SwapMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0001739940 us-gaap:SwapMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001739940 ci:UnobservableInputsDevelopedByCompanyMember ci:CorporateAndGovernmentDebtSecuritiesMember srt:MaximumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 ci:UnobservableInputsDevelopedByCompanyMember ci:CorporateAndGovernmentDebtSecuritiesMember srt:MinimumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0001739940 ci:UnobservableInputsDevelopedByCompanyMember ci:CorporateAndGovernmentDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember 2018-12-31 0001739940 ci:UnobservableInputsDevelopedByCompanyMember srt:MaximumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001739940 ci:UnobservableInputsDevelopedByCompanyMember srt:MinimumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001739940 ci:UnobservableInputsDevelopedByCompanyMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember srt:WeightedAverageMember 2018-12-31 0001739940 ci:SeparateAccountAssetsMember 2019-01-01 2019-12-31 0001739940 ci:SeparateAccountAssetsMember 2018-01-01 2018-12-31 0001739940 ci:SeparateAccountAssetsMember us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember 2019-01-01 2019-12-31 0001739940 srt:MaximumMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DebtSecuritiesMember 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DebtSecuritiesMember ci:UnobservableInputsNotDevelopedByCompanyMember 2018-12-31 0001739940 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryAggregatedDisclosureMember 2019-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001739940 ci:AccumulatedDefinedBenefitPlansAdjustmentSettlementMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001739940 ci:AccumulatedDefinedBenefitPlansAdjustmentSettlementMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001739940 us-gaap:AccountingStandardsUpdate201613Member 2019-01-01 2019-12-31 0001739940 us-gaap:LetterOfCreditMember ci:RevolvingCreditAndLetterOfCreditFacilityMember 2019-12-31 0001739940 2019-06-30 0001739940 us-gaap:ProductMember 2017-01-01 2017-12-31 0001739940 ci:GroupDisabilityAndLifeMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2019-12-31 0001739940 us-gaap:CommonStockMember 2016-12-31 0001739940 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001739940 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001739940 us-gaap:RetainedEarningsMember 2016-12-31 0001739940 us-gaap:TreasuryStockMember 2016-12-31 0001739940 us-gaap:NoncontrollingInterestMember 2016-12-31 0001739940 us-gaap:ParentMember 2016-12-31 0001739940 us-gaap:TreasuryStockMember 2017-01-01 2017-12-31 0001739940 us-gaap:ParentMember 2017-01-01 2017-12-31 0001739940 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001739940 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001739940 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-12-31 0001739940 ci:OldCignaPreAcquisitionMember 2018-12-21 2018-12-31 0001739940 ci:OldCignaPreAcquisitionMember 2018-12-20 0001739940 2018-12-21 2018-12-31 0001739940 ci:ExpressScriptsHoldingCompanyMember 2018-12-20 0001739940 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:ForeignGovernmentDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember 2019-12-31 0001739940 us-gaap:EquitySecuritiesMember 2019-12-31 0001739940 us-gaap:MortgagesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:PolicyLoansMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member 2019-12-31 0001739940 us-gaap:ShortTermInvestmentsMember 2019-12-31 0001739940 us-gaap:OtherLongTermInvestmentsMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:SwapMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:SwapMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:SwapMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:SwapMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DebtSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DebtSecuritiesMember ci:UnobservableInputsNotDevelopedByCompanyMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member ci:UnobservableInputsDevelopedByCompanyMember ci:CorporateAndGovernmentDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember ci:UnobservableInputsDevelopedByCompanyMember 2019-12-31 0001739940 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001739940 us-gaap:USStatesAndPoliticalSubdivisionsMember 2019-12-31 0001739940 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001739940 srt:MaximumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member ci:UnobservableInputsDevelopedByCompanyMember ci:CorporateAndGovernmentDebtSecuritiesMember 2019-12-31 0001739940 srt:MinimumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member ci:UnobservableInputsDevelopedByCompanyMember ci:CorporateAndGovernmentDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member srt:WeightedAverageMember ci:UnobservableInputsDevelopedByCompanyMember ci:CorporateAndGovernmentDebtSecuritiesMember 2019-12-31 0001739940 srt:MaximumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember ci:UnobservableInputsDevelopedByCompanyMember 2019-12-31 0001739940 srt:MinimumMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember ci:UnobservableInputsDevelopedByCompanyMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:AssetBackedSecuritiesMember srt:WeightedAverageMember ci:UnobservableInputsDevelopedByCompanyMember 2019-12-31 0001739940 ci:RunoffSettlementAnnuityBusinessMember 2019-12-31 0001739940 ci:DebtAndEquitySecuritiesMember 2019-12-31 0001739940 us-gaap:FairValueInputsLevel1Member 2019-12-31 0001739940 us-gaap:FairValueInputsLevel2Member 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:InvestmentGradeMember 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:InvestmentGradeMember ci:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsMember 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:InvestmentGradeMember ci:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerMember 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:BelowInvestmentGradeMember 2019-12-31 0001739940 us-gaap:FairValueInputsLevel3Member 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:BelowInvestmentGradeMember ci:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsMember 2019-12-31 0001739940 us-gaap:DebtSecuritiesMember ci:BelowInvestmentGradeMember ci:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerMember 2019-12-31 0001739940 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001739940 ci:LtvLessThan60PercentMember 2019-12-31 0001739940 ci:Ltv60To79PercentMember 2019-12-31 0001739940 us-gaap:Ltv80To100PercentMember 2019-12-31 0001739940 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0001739940 srt:WeightedAverageMember 2019-01-01 2019-12-31 0001739940 srt:WeightedAverageMember ci:LtvLessThan60PercentMember 2019-01-01 2019-12-31 0001739940 srt:WeightedAverageMember ci:Ltv60To79PercentMember 2019-01-01 2019-12-31 0001739940 us-gaap:Ltv80To100PercentMember srt:WeightedAverageMember 2019-01-01 2019-12-31 0001739940 us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001739940 us-gaap:ForeignGovernmentDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:MoneyMarketFundsMember 2019-12-31 0001739940 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:FairValueHedgingMember us-gaap:CurrencySwapMember 2019-12-31 0001739940 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CurrencySwapMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0001739940 us-gaap:NondesignatedMember us-gaap:ForwardContractsMember 2019-12-31 0001739940 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-12-31 0001739940 ci:TaxExpenseMember 2017-01-01 2017-12-31 0001739940 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0001739940 us-gaap:InterestExpenseMember 2018-01-01 2018-12-31 0001739940 ci:NetInvestmentIncomeMember 2018-01-01 2018-12-31 0001739940 us-gaap:OperatingSegmentsMember ci:HealthServicesMember 2017-01-01 2017-12-31 0001739940 us-gaap:OperatingSegmentsMember ci:IntegratedMedicalMember 2017-01-01 2017-12-31 0001739940 us-gaap:OperatingSegmentsMember ci:InternationalMarketsMember 2017-01-01 2017-12-31 0001739940 us-gaap:OperatingSegmentsMember ci:GroupDisabilityAndOtherMember 2017-01-01 2017-12-31 0001739940 ci:CorporateAndEliminationsMember 2017-01-01 2017-12-31 0001739940 ci:HealthServicesMember 2017-01-01 2017-12-31 0001739940 ci:GroupDisabilityAndOtherMember 2017-01-01 2017-12-31 0001739940 us-gaap:CorporateNonSegmentMember 2017-01-01 2017-12-31 0001739940 us-gaap:IntersegmentEliminationMember 2017-01-01 2017-12-31 0001739940 us-gaap:IntersegmentEliminationMember ci:HealthServicesMember 2017-01-01 2017-12-31 0001739940 us-gaap:IntersegmentEliminationMember ci:IntegratedMedicalMember 2017-01-01 2017-12-31 0001739940 us-gaap:IntersegmentEliminationMember ci:InternationalMarketsMember 2017-01-01 2017-12-31 0001739940 us-gaap:IntersegmentEliminationMember ci:GroupDisabilityAndOtherMember 2017-01-01 2017-12-31 0001739940 srt:MaximumMember us-gaap:GeographicConcentrationRiskMember ci:RevenuesFromExternalCustomersMember 2019-01-01 2019-12-31 0001739940 srt:MaximumMember us-gaap:GeographicConcentrationRiskMember ci:RevenuesFromExternalCustomersMember 2018-01-01 2018-12-31 0001739940 srt:MaximumMember us-gaap:GeographicConcentrationRiskMember ci:RevenuesFromExternalCustomersMember 2017-01-01 2017-12-31 0001739940 us-gaap:GeographicConcentrationRiskMember ci:RevenuesFromExternalCustomersMember 2019-01-01 2019-12-31 0001739940 ci:TurkeyJointVentureMember 2019-12-31 0001739940 us-gaap:AccountingStandardsUpdate201704Member 2019-01-01 2019-12-31 0001739940 us-gaap:OtherNoncurrentAssetsMember 2019-12-31 0001739940 ci:LongTermInvestmentsMember 2019-12-31 0001739940 ci:ExpressScriptsHoldingCompanyMember 2018-12-20 2018-12-20 0001739940 ci:HealthServicesMember ci:ExpressScriptsHoldingCompanyMember 2018-12-20 0001739940 us-gaap:CustomerRelationshipsMember ci:ExpressScriptsHoldingCompanyMember 2018-12-20 2018-12-20 0001739940 ci:ExpressScriptsHoldingCompanyMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-12-20 2018-12-20 0001739940 ci:ExpressScriptsHoldingCompanyMember us-gaap:TradeDressMember 2018-12-20 2018-12-20 0001739940 srt:MinimumMember us-gaap:CustomerRelationshipsMember ci:ExpressScriptsHoldingCompanyMember 2018-12-20 2018-12-20 0001739940 srt:MaximumMember us-gaap:CustomerRelationshipsMember ci:ExpressScriptsHoldingCompanyMember 2018-12-20 2018-12-20 0001739940 srt:MinimumMember ci:ExpressScriptsHoldingCompanyMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-12-20 2018-12-20 0001739940 srt:MaximumMember ci:ExpressScriptsHoldingCompanyMember us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2018-12-20 2018-12-20 0001739940 ci:ExpressScriptsHoldingCompanyMember 2018-01-01 2018-12-31 0001739940 ci:ExpressScriptsHoldingCompanyMember 2017-01-01 2017-12-31 0001739940 ci:InternationalMarketsAndGroupDisabilityAndOtherMember 2019-12-31 0001739940 ci:IntegratedMedicalMember 2016-12-31 0001739940 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member ci:IntegratedMedicalMember 2018-12-31 0001739940 us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member ci:IntegratedMedicalMember 2019-12-31 0001739940 ci:IntegratedMedicalMember ci:ShortdurationInsuranceContractsAccidentYear2019Member 2019-12-31 0001739940 ci:GroupDisabilityAndOtherMember 2019-12-31 0001739940 ci:GroupDisabilityAndLifeMember 2019-12-31 0001739940 us-gaap:AllOtherSegmentsMember 2019-12-31 0001739940 srt:MinimumMember 2019-12-31 0001739940 srt:MinimumMember 2018-12-31 0001739940 ci:InternationalMarketsGroupDisabilityAndLifeMember 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2012Member 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember ci:ShortdurationInsuranceContractsAccidentYear2019Member 2019-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2012Member 2018-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member 2018-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member 2018-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member 2018-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2018-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2018-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortDurationInsuranceContractsAccidentYear2018Member 2018-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2012Member 2017-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member 2017-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member 2017-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member 2017-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2017-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortDurationInsuranceContractsAccidentYear2017Member 2017-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2012Member 2016-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member 2016-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member 2016-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member 2016-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2016Member 2016-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2012Member 2015-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member 2015-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member 2015-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2015Member 2015-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2012Member 2014-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member 2014-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2014Member 2014-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2012Member 2013-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2013Member 2013-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember us-gaap:ShortdurationInsuranceContractsAccidentYear2012Member 2012-12-31 0001739940 us-gaap:DisabilityInsurancePolicyMember ci:GroupDisabilityAndLifeMember 2019-12-31 0001739940 us-gaap:OtherShortdurationInsuranceProductLineMember ci:GroupDisabilityAndLifeMember 2019-12-31 0001739940 us-gaap:GuaranteedMinimumIncomeBenefitMember 2017-01-01 2017-12-31 0001739940 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:EmployeeSeveranceMember 2019-10-01 2019-12-31 0001739940 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001739940 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001739940 srt:MinimumMember us-gaap:PerformanceSharesMember 2019-12-31 0001739940 srt:MaximumMember us-gaap:PerformanceSharesMember 2019-12-31 0001739940 srt:ParentCompanyMember 2018-01-01 2018-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember ci:SeparateAccountAssetsMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember srt:PartnershipInterestMember ci:SeparateAccountAssetsMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:RealEstateFundsMember ci:SeparateAccountAssetsMember 2019-12-31 0001739940 us-gaap:FairValueMeasurementsRecurringMember us-gaap:HedgeFundsMember ci:SeparateAccountAssetsMember 2019-12-31 0001739940 srt:ParentCompanyMember 2018-12-31 0001739940 srt:ParentCompanyMember 2017-12-31 0001739940 us-gaap:DebtSecuritiesMember 2017-01-01 2017-12-31 0001739940 ci:OtherInvestmentMember 2017-01-01 2017-12-31 0001739940 us-gaap:EquitySecuritiesMember 2019-01-01 2019-12-31 0001739940 srt:MinimumMember ci:RestrictedStockGrantsAndUnitsMember 2019-01-01 2019-12-31 0001739940 srt:MaximumMember ci:RestrictedStockGrantsAndUnitsMember 2019-01-01 2019-12-31 0001739940 ci:InternationalMarketsAndGroupDisabilityAndOtherMember 2019-01-01 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:QualifiedPlanMember 2019-01-01 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:QualifiedPlanMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:NonqualifiedPlanMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:DebtSecuritiesMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:AssetBackedSecuritiesMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:FundInvestmentsAndPooledSeparateAccountsMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:FundInvestmentsAndPooledSeparateAccountsMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:EquitySecuritiesDomesticMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:EquitySecuritiesDomesticMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:EquitySecuritiesInternationalIncludingFundsAndPooledSeperateAccountsMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:EquitySecuritiesInternationalIncludingFundsAndPooledSeperateAccountsMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:EquitySecuritiesMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:SecuritiesPartnershipsMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:SecuritiesPartnershipsMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:RealEstateMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:RealEstateMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:MortgagesMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:MortgagesMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:HedgeFundsMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember us-gaap:HedgeFundsMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:GuaranteedDepositAccountContractMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:GuaranteedDepositAccountContractMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:CashAndCashEquivalentsInvestmentTradeReceivablesNetMember 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:CashAndCashEquivalentsInvestmentTradeReceivablesNetMember 2018-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember ci:OtherPlanAssetCategoriesMember 2019-12-31 0001739940 us-gaap:TradeNamesMember 2019-12-31 0001739940 us-gaap:TradeNamesMember 2018-12-31 0001739940 ci:AssetsHeldUnderCapitalLeasesAndOtherCapitalizedPropertyPlantAndEquipmentMember 2018-12-31 0001739940 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2019-12-31 0001739940 ci:AssetsHeldUnderCapitalLeasesAndOtherCapitalizedPropertyPlantAndEquipmentMember 2019-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:AccountingStandardsUpdate201802Member 2016-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:AccountingStandardsUpdate201601Member 2016-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:AccountingStandardsUpdate201712Member 2016-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0001739940 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-12-31 0001739940 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2017-01-01 2017-12-31 0001739940 ci:AccumulatedDefinedBenefitPlansAdjustmentSettlementMember 2017-01-01 2017-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-01-01 2017-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001739940 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember ci:AccumulatedDefinedBenefitPlansAdjustmentSettlementMember 2017-01-01 2017-12-31 0001739940 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001739940 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001739940 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-12-31 0001739940 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0001739940 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0001739940 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-12-31 0001739940 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-12-31 0001739940 us-gaap:RevolvingCreditFacilityMember ci:RevolvingCreditAgreemen364DayMember 2019-12-31 0001739940 us-gaap:RevolvingCreditFacilityMember ci:RevolvingCreditAgreemen364DayMember 2019-01-01 2019-12-31 0001739940 us-gaap:RevolvingCreditFacilityMember 2019-12-31 0001739940 us-gaap:RevolvingCreditFacilityMember ci:RevolvingCreditAndLetterOfCreditFacilityMember 2019-01-01 2019-12-31 0001739940 us-gaap:RevolvingCreditFacilityMember ci:RevolvingCreditAndLetterOfCreditFacilityMember 2019-12-31 0001739940 ci:TermLoanCreditAgreementMember 2019-12-31 0001739940 us-gaap:CommercialPaperMember ci:NotesIssue2018ExpressScriptsMergerMemberMember 2018-07-01 2018-09-30 0001739940 srt:MaximumMember ci:SecurityAndRealEstateLimitedPartnershipsMember 2019-01-01 2019-12-31 0001739940 srt:MaximumMember ci:InvestmentEntitiesMember 2019-01-01 2019-12-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0001739940 us-gaap:PensionPlansDefinedBenefitMember 2018-10-01 2018-12-31 0001739940 ci:AcquisitionDispositionRunoffActivitiesMember 2019-12-31 0001739940 ci:LincolnNationalLifeInsuranceCompanyAndLincolnLifeAndAnnuityOfNewYorkMember ci:IndividualLifeInsuranceAndAnnuityMember 2019-12-31 0001739940 ci:BerkshireHathwayLifeInsuranceCompanyOfNebraskaMember ci:GuaranteedMinimumDeathBenefitsMember 2019-12-31 0001739940 ci:PrudentialRetirementInsuranceAndAnnuityCompanyMember ci:RetirementBenefitsMember 2019-12-31 0001739940 ci:GreatAmericanLifeInsuranceCompanyMember ci:LifeInsuranceAndAnnuityAcquiredFromGreatAmericanMember 2019-12-31 0001739940 ci:OtherRetrocessionairesMember ci:OtherRunoffMember 2019-12-31 0001739940 ci:OtherRetrocessionairesMember ci:OngoingOperationsMember 2019-12-31 0001739940 ci:OtherRetrocessionairesMember ci:IntegratedMedicalInternationalMarketsGroupDisabilityColiMember 2019-12-31 0001739940 us-gaap:PerformanceGuaranteeMember ci:PharmacyBenefitsManagementServicesMember 2019-12-31 0001739940 us-gaap:PerformanceGuaranteeMember ci:PharmacyBenefitsManagementServicesMember 2018-12-31 0001739940 us-gaap:PerformanceGuaranteeMember ci:AdministrativeServicesOnlyHealthCareServicesMember 2019-01-01 2019-12-31 0001739940 us-gaap:PerformanceGuaranteeMember ci:AdministrativeServicesOnlyHealthCareServicesMember 2018-01-01 2018-12-31 0001739940 us-gaap:PerformanceGuaranteeMember ci:AdministrativeServicesOnlyHealthCareServicesMember 2017-01-01 2017-12-31 0001739940 srt:MaximumMember us-gaap:StockholdersEquityTotalMember us-gaap:InvestmentsMember 2019-01-01 2019-12-31 0001739940 srt:MaximumMember us-gaap:StockholdersEquityTotalMember us-gaap:InvestmentsMember 2018-01-01 2018-12-31 0001739940 ci:ExpressScriptsHoldingCompanyMember 2018-12-31 0001739940 ci:NotesDue20204125InterestMember 2019-01-01 2019-12-31 0001739940 srt:ParentCompanyMember ci:ExpressScriptsHoldingCompanyMember 2019-01-01 2019-12-31 0001739940 srt:ParentCompanyMember ci:OldCignaPreAcquisitionMember 2019-01-01 2019-12-31 0001739940 srt:ParentCompanyMember ci:OldCignaPreAcquisitionMember 2018-01-01 2018-12-31 0001739940 srt:ParentCompanyMember ci:ExpressScriptsHoldingCompanyMember 2019-12-31 0001739940 srt:ParentCompanyMember ci:NotesDue20204125InterestMember 2019-01-01 2019-12-31 0001739940 srt:ParentCompanyMember ci:NotesDue20204125InterestMember 2019-12-31 0001739940 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001739940 ci:ExpressScriptsHoldingCompanyMember 2018-01-01 2018-12-31 0001739940 srt:ParentCompanyMember ci:NotesIssue2018ExpressScriptsMergerMemberMember 2019-07-01 2019-09-30 0001739940 srt:ParentCompanyMember 2019-10-01 2019-12-31 0001739940 us-gaap:GeographicConcentrationRiskMember ci:IncomeBeforeTaxesMember 2019-01-01 2019-12-31 0001739940 us-gaap:GeographicConcentrationRiskMember ci:IncomeBeforeTaxesMember 2018-01-01 2018-12-31 0001739940 us-gaap:GeographicConcentrationRiskMember ci:IncomeBeforeTaxesMember 2017-01-01 2017-12-31 0001739940 ci:AccruedExpensesAndOtherLiabilitiesMember 2019-12-31 0001739940 us-gaap:OtherNoncurrentLiabilitiesMember 2019-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember ci:NetRealizedInvestmentGainsLossesMember 2019-01-01 2019-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember ci:NetRealizedInvestmentGainsLossesMember 2018-01-01 2018-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember ci:NetRealizedInvestmentGainsLossesMember 2017-01-01 2017-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember ci:OtherOperatingExpensesMember 2019-01-01 2019-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember ci:OtherOperatingExpensesMember 2018-01-01 2018-12-31 0001739940 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember ci:OtherOperatingExpensesMember 2017-01-01 2017-12-31 0001739940 ci:LoanDue2021FloatingRateInterestMember 2019-01-01 2019-12-31 0001739940 ci:LongTermDebtCurrentMaturitiesPaidMember 2019-01-01 2019-12-31 0001739940 srt:ParentCompanyMember ci:OldCignaPreAcquisitionMember 2019-12-31 0001739940 srt:ParentCompanyMember ci:OldCignaPreAcquisitionMember 2018-12-31 iso4217:USD xbrli:pure xbrli:shares iso4217:USD xbrli:shares ci:Contractholders ci:Employees ci:Reinsurers ci:Banks ci:LimitedPartnerships ci:Claims




Washington, D.C. 20549

Picture 1


(Mark One)


For the fiscal year ended December 31, 2019



For the transition period from ______________ to ______________

Commission file number 001-38769



Cigna Corporation

(Exact name of registrant as specified in its charter)





(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

900 Cottage Grove Road, Bloomfield, Connecticut


(Address of principal executive offices)

(Zip Code)

(860) 226-6000

Registrant’s telephone number, including area code


Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, Par Value $0.01


New York Stock Exchange, Inc.


Securities registered pursuant to Section 12(g) of the Act:




Indicate by check mark



if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act

whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days

whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)

whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer


Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).


The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 28, 2019 was approximately $59.4 billion.

As of January 31, 2020, 372,043,094 shares of the registrant’s Common Stock were outstanding.



Part III of this Form 10-K incorporates by reference information from the registrant’s definitive proxy statement related to the 2020 annual meeting of shareholders.









Risk Factors


Executive Overview


Industry Developments and Other Matters


Liquidity and Capital Resources


Critical Accounting Estimates


Segment Information


Revenues by Product Type







Cautionary Statement





Item 1.







. Health Services



. Integrated Medical



. International Markets



. Group Disability and Other



. Investment Management



. Miscellaneous



. Regulation


Item 1A.

Risk Factors


Item 1B.

Unresolved Staff Comments


Item 2.



Item 3.

Legal Proceedings


Item 4.

Mine Safety Disclosures



Information about our Executive Officers








Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer
Purchases of Equity Securities


Item 6.

Selected Financial Data


Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of



Operations (“MD&A”)


Item 7A.

Quantitative and Qualitative Disclosures about Market Risk


Item 8.

Financial Statements and Supplementary Data


Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial





Item 9A.

Controls and Procedures


Item 9B.


Other Information







Item 10.

Directors, Executive Officers and Corporate Governance.



A. Directors of the Registrant



B. Executive Officers of the Registrant



C. Code of Ethics and Other Corporate Governance Disclosures



D. Delinquent Section 16(a) Reports


Item 11.

Executive Compensation


Item 12.

Security Ownership of Certain Beneficial Owners and Management and



Related Stockholder Matters


Item 13.

Certain Relationships and Related Transactions, and Director Independence.


Item 14.

Principal Accountant Fees and Services










Item 15.

Exhibits and Financial Statement Schedules







This Annual Report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on Cigna’s current expectations and projections about future trends, events and uncertainties. These statements are not historical facts. Forward-looking statements may include, among others, statements concerning future financial or operating performance, including our ability to deliver affordable, personalized and innovative solutions for our customers and clients; future growth, business strategy, strategic or operational initiatives, including our organizational efficiency plan; economic, regulatory or competitive environments, particularly with respect to the pace and extent of change in these areas; financing or capital deployment plans and amounts available for future deployment; our prospects for growth in the coming years; strategic transactions, including the merger (“Merger”) with Express Scripts Holding Company and the sale of our Group Disability and Life business; and other statements regarding Cigna’s future beliefs, expectations, plans, intentions, financial condition or performance. You may identify forward-looking statements by the use of words such as “believe,” “expect,” “plan,” “intend,” “anticipate,” “estimate,” “predict,” “potential,” “may,” “should,” “will” or other words or expressions of similar meaning, although not all forward-looking statements contain such terms.


Forward-looking statements are subject to risks and uncertainties, both known and unknown, that could cause actual results to differ materially from those expressed or implied in forward-looking statements. Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical and pharmacy costs and price effectively; our ability to adapt to changes or trends in an evolving and rapidly changing industry; our ability to effectively differentiate our products and services from those of our competitors and maintain or increase market share; our ability to develop and maintain good relationships with physicians, hospitals, other health care providers, producers, consultants and pharmaceutical manufacturers; changes in the pharmacy provider marketplace or pharmacy networks; changes in drug pricing; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits (including anticipated synergies) of such transactions in full or within the anticipated time frame, including with respect to the Merger and sale of our Group Disability and Life business, as well as our ability to integrate or separate operations, resources and systems; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions or guaranty fund assessments; uncertainties surrounding participation in government-sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems and those of our key suppliers or other third parties; the impact of our debt service obligations on the availability of funds for other business purposes; unfavorable industry, economic or political conditions, including foreign currency movements; acts of civil unrest, war, terrorism, natural disasters or pandemics; reinsurance credit risk; as well as more specific risks and uncertainties discussed in Part I, Item 1A – Risk Factors and Part II, Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations of this Form 10-K and as described from time to time in our future reports filed with the Securities and Exchange Commission (the “SEC”).


You should not place undue reliance on forward-looking statements, which speak only as of the date they are made, are not guarantees of future performance or results, and are subject to risks, uncertainties and assumptions that are difficult to predict or quantify. Cigna undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.








Cigna Corporation, together with its subsidiaries (either individually or collectively referred to as “Cigna,” the “Company,” “we,” “our” or “us”) is a global health service organization.



Our Mission

To improve the health, well-being and peace of mind of those we serve



Our Strategy


Go Deeper: To expand and deepen our customer, client and partner relationships and create depth in targeted sub-segments and geographies


Go Local: To ensure our solution suite and services meet customer, client and partner needs at a local market level



Go Beyond: To innovate and further differentiate our businesses, the experiences we deliver and our overall social impact



How We Win

Picture 1



Cigna is an enterprise uniquely capable of delivering affordability, predictability and simplicity of health care to those we serve. We have broad and deep capabilities that accelerate our strategy to achieve our mission of improving the health, well-being and peace of mind of those we serve. Cigna’s employees are champions for the people we serve and over the past decade, our focus has shifted to helping people thrive by offering solutions to prevent and better manage health challenges. When sickness or disability do occur, we support our customers’ ability to have broad choices in how they best access high quality, affordable care. We see three primary ways to help individuals maintain, improve or recover their physical or mental health: 1) behavioral and lifestyle changes – with over 1,000 health coaches helping individuals set and meet health goals; 2) pharmaceutical interventions – with our leading pharmacy services improving health and driving affordability; and 3) medical and surgical interventions – with a clear and proven strategy around partnerships and value-based care programs, powered by applied informatics and aligned incentives. We maximize use of evidence-based care, while delivering best-in-class quality of care for our customers with acute and chronic conditions through enhanced real-time data across an expanded platform with industry-leading solutions to support care decisions.


We offer a differentiated set of pharmacy, medical, behavioral, dental, disability, life and accident insurance and related products and services. Our capabilities include: 1) a broad portfolio of specialty services, some of which can be offered on a stand-alone basis; 2) integrated behavioral, medical and pharmacy management services; 3) leading specialty pharmacy expertise; and 4) advanced analytics that help us engage more meaningfully with individuals, plan sponsors we serve and our provider partners. These capabilities enhance Cigna’s ability to drive improved cost affordability, quality of care and predictability.


We put medicine within reach for patients and help providers improve access to prescription drugs by making them more affordable. We improve patient outcomes and better manage the cost of the pharmacy benefit by:


Identifying products and offering innovative solutions that improve patient outcomes and control costs

Evaluating medicines for efficacy, value and price to assist clients in selecting a cost-effective formulary


Offering home delivery and specialty services that save money for clients and customers while providing better and specialized clinical care

Leveraging purchasing volume to deliver discounts drive risk-sharing and value-based care across the pharmaceutical supply chain

Promoting the use of generics and lowest cost, clinically effective brands of medications


We work with key stakeholders across the health care system to improve health outcomes and patient satisfaction, increase efficiency in drug distribution and manage costs of the pharmacy benefit. In 2019, we launched three major initiatives: 1) the Patient AssuranceSM program that offers diabetic customers a low, fixed monthly out-of-pocket cost for insulin; 2) the Embarc Benefit ProtectionSM program that improves care, access and affordability for potentially life-changing medicines that are extremely costly and 3) our Digital Health Formulary that helps clients and customers get the most value from innovative digital health products. Plan sponsors and participants can achieve the best health and financial outcomes when they use our comprehensive set of solutions to manage drug spend.


We present the financial results of our businesses in the following segments:


Health Services includes pharmacy benefits management, specialty pharmacy services, clinical solutions, home delivery and health management services.


Integrated Medical offers a variety of health care solutions to employers and individuals.


The Commercial operating segment serves employers (also referred to as “clients”) and their employees (also referred to as “customers”) and other groups. This segment provides deeply integrated medical and specialty offerings including medical, pharmacy, behavioral health, dental, vision, health advocacy programs and other products and services to insured and self-insured clients.

The Government operating segment offers Medicare Advantage, Medicare Supplement, and Medicare Part D plans (including the acquired Express Scripts’ Medicare Part D business) for seniors, Medicaid plans and individual health insurance coverage both on and off the public exchanges.


International Markets includes supplemental health, life and accident insurance products and health care coverage in our international markets as well as health care benefits to globally mobile employees of multinational organizations.


Group Disability and Other contains the remainder of our business operations, consisting of the following:


Group Disability and Life provides group long-term and short-term disability, group life, accident, voluntary and specialty insurance products and related services.

Corporate-Owned Life Insurance (“COLI”) offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations.

Run-off businesses:

Reinsurance: predominantly comprised of guaranteed minimum death benefit (“GMDB”) and guaranteed minimum income benefit (“GMIB”) business effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska (“Berkshire”) in 2013.

Settlement Annuity business in run-off.

Individual Life Insurance and Annuity and Retirement Benefits Businesses: comprised of deferred gains from the sales of these businesses.


Other Information


The financial information included in this Form 10-K for the fiscal year ended December 31, 2019 is in conformity with accounting principles generally accepted in the United States of America (“GAAP”) unless otherwise indicated. In the segment discussions that follow, we use the terms “adjusted revenues” and “pre-tax adjusted income from operations” to describe segment results. See the introduction to the Management Discussion and Analysis section of this Form 10-K for definitions of those terms. Industry rankings and percentages set forth herein are for the year ended December 31, 2019 unless otherwise indicated. In addition, statements set forth in this document concerning our rank or position in an industry or particular line of business have been developed internally based on publicly available information unless otherwise noted.



Cigna Holding Company (formerly Cigna Corporation) was incorporated in Delaware in 1981. Halfmoon Parent, Inc. was incorporated in Delaware in March 2018. Halfmoon Parent, Inc. was renamed Cigna Corporation concurrent with the consummation of the combination with Express Scripts on December 20, 2018.


You can access our website at http://www.cigna.com to learn more about our company. We make annual, quarterly and current reports and proxy statements and amendments to those reports available, free of charge through our website (http://www.cigna.com, under the “Investors—Quarterly Reports and SEC Filings” captions) as soon as reasonably practicable after we electronically file these materials with, or furnish them to, the Securities and Exchange Commission (the “SEC”). We also use our website as a means of disclosing material information and for complying with our disclosure obligations under the SEC’s Regulation FD (Fair Disclosure). Important information, including news releases, analyst presentations and financial information regarding Cigna is routinely posted on and accessible at http://www.cigna.com. Accordingly, investors should monitor the Investor Relations portion of our website, in addition to following our press releases, SEC filings and public conference calls and webcasts. The information contained on, or that may be accessed through, our website is neither incorporated by reference into nor a part of this report. See also “Code of Ethics and Other Corporate Governance Disclosures” in Part III, Item 10 of this Form 10-K for additional information regarding the availability of our Codes of Ethics on our website.





This segment consists of pharmacy benefit management, home delivery and specialty pharmacy and certain health management services. In 2019, Health Services reported adjusted revenues of $96.4 billion and pre-tax adjusted income from operations of $5.1 billion.



Creating innovative solutions that improve patient outcomes and control costs

Evaluating medicines for efficacy, value and price to assist clients in selecting a cost-effective formulary

Offering home delivery and specialty services that save money for clients and customers, while providing better and specialized clinical care

Leveraging purchasing volume to deliver discounts and drive risk-sharing and value-based care across the pharmaceutical supply chain

Promoting the use of generics and lowest-cost, clinically effective brands of medications



The following chart depicts a high-level summary of our principal products and services in this segment with definitions on subsequent pages.


Principal Products & Services



Key Relationships

Primary Competitors

Pharmacy Dispensing

Accredo®, Therapeutic Resource Centers®, Express Scripts Pharmacy SM, Cigna Home Delivery Pharmacy

Clients, Customers, Providers

Independent Pharmacy Benefit Managers (“PBMs”), Managed Care PBMs, Retail Pharmacies, Specialty Pharmacies

Supply Chain Administration and Management

Express Scripts, Smart90®, SmartShareRx®, Ascent Health Services, Econdisc

Clients, Customers

Independent PBMs, Managed Care PBMs, Third Party Benefit Administrators, Group Purchasing Organizations

Clinical Solutions

Health Connect 360SM, Advanced Utilization Management, Express Scripts Digital Health Formulary, Fraud, Waste & Abuse

Clients, Customers

Independent PBMs, Managed Care PBMs, Third-Party Benefit Administrators

Value-Based Programs

SafeGuardRx®, Express Scripts Patient AssuranceSM,Embarc Benefit Protection SM

Clients, Customers

Independent PBMs, Managed Care PBMs

Provider Services

CuraScript SD®

Health Care Providers, Clinics, Hospitals

Specialty Drug Distributors

Health Benefit Management Services


Health Plans, Commercial and Government Payors

Health Plans, Third-Party Benefits Administrators, Clinical Solutions and Health Care Data Analytics Companies


Principal Products & Services


Pharmacy Benefit Management Services: Our services drive high-quality, cost-effective care through prescription drug utilization and cost management. We support our clients’ plan design selections to deliver balanced affordability, choice, simplicity and convenience. We focus our solutions to align with our clients’ needs across care, cost and service. As a result, we believe we deliver better outcomes, higher customer satisfaction and a more affordable prescription drug benefit. The home delivery pharmacy operations of our Health Services segment consist of eight order processing pharmacies, eight patient contact centers and four high-volume automated home delivery dispensing pharmacies located throughout the United States. Health Services’ home delivery dispensing pharmacies are located in Arizona, Indiana, Missouri and New Jersey. Health Services also has seven specialty home delivery pharmacies and 38 specialty branch pharmacies.


Pharmacy Dispensing:

oHome Delivery Pharmacy Services: In addition to the order processing that occurs at our home delivery pharmacies, we operate several non-dispensing prescription processing facilities and customer contact centers. Our pharmacies provide greater safety and accuracy than retail pharmacies, convenient access to maintenance medications and better management of our clients’ drug costs through operating efficiencies. We are directly involved with the prescriber and customer through our home delivery pharmacies and our research shows that we achieve a higher level of generic substitutions, therapeutic interventions and better adherence than is achieved through retail pharmacy networks.

oSpecialty Pharmacy Services: Specialty medications are used primarily for the treatment of complex diseases. These medications are broadly characterized to include those with frequent dosing adjustments, intensive clinical monitoring, the need for customer training, specialized product administration requirements or medications limited to certain specialty pharmacy networks by manufacturers. Through a combination of assets and capabilities, we provide an enhanced level of predictable care and therapy management for customers taking specialty medications and increased visibility and improved outcomes for payors, as well as custom programs for biopharmaceutical manufacturers. Accredo Health Group (“Accredo”) is focused on dispensing injectable, infused, oral or inhaled drugs that require a higher level of clinical service and support than traditional pharmacies typically offer. Accredo supports successful outcomes for c


ustomers and reduces waste for clients through specialty trained clinicians, a nationwide footprint, and a network of in-home nursing services, reimbursement and customer assistance programs and biopharmaceutical services.

oDrug Claim Adjudication: We process drug claims for home delivery, specialty, or retail networks by integrating retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management and pharmacy fulfillment services. We administer payments to retail networks and bill benefits costs to our clients through our end-to-end adjudication services.

oDrug Utilization Review program: When pharmacies submit claims for prescription drugs to us, we review them electronically in real time for health and safety. We then alert the dispensing pharmacy of any detected issues. Clients may also choose to enroll in programs that result in communications about potential therapy concerns being sent to prescribers after the initial claim submission.

Supply Chain Administration and Management:

oRetail Network Pharmacy Administration: We contract with retail pharmacies to provide prescription drugs to customers of the pharmacy benefit plans we manage. In the United States, Puerto Rico and the Virgin Islands, we negotiate with pharmacies to discount drug prices provided to customers and manage national and regional networks responsive to client preferences related to cost containment, convenience of access for customers and network performance. We also manage networks of pharmacies customized for or under direct contract with specific clients and have contracted with pharmacy provider networks to comply with the Center for Medicare and Medicaid Services (“CMS”) access requirements for the federal Medicare Part D prescription drug program (“Medicare Part D”). All retail pharmacies in our network communicate with us online and in real-time to process prescription drug claims. When a plan customer presents their identification card at a network pharmacy, the pharmacy sends specific customer, prescriber and prescription information in an industry-standard format through our systems, which process the claim and respond to the pharmacy with relevant information to process the prescription.

oBenefits Design Consultation: We consult with our clients on how best to structure and leverage the pharmacy benefit to meet plan objectives for affordable access to the prescription medications people need to stay healthy, and ensure the safe and effective use of those medications.

oDrug Formulary Management: Formularies are lists of drugs with designations that may be used to determine drug coverage, customer out-of-pocket costs and communicate plan preferences in competitive drug categories. Our formulary management services support clients in establishing formularies that assist customers and physicians in choosing clinically-appropriate, cost-effective drugs and prioritize access, safety and affordability. We administer specific formularies on behalf of our clients, including standard formularies developed and offered by Express Scripts and custom formularies in which we play a more limited role. Most of our clients select standard formularies, governed by our National Pharmacy & Therapeutics Committee comprised of a panel of independent physicians and pharmacists in active clinical practice representing a variety of specialties and practice settings, typically with major academic affiliations. In making formulary recommendations, this committee considers only the drug’s safety and efficacy and not the cost of the drug, including any negotiated manufacturer discount or rebate arrangement. This process is designed to ensure the clinical recommendation is not affected by our financial arrangements. We fully comply with this committee’s clinical recommendations regarding drugs that must be included or excluded from the formulary based on their assessment of safety and efficacy.

oAdministration of Group Purchasing Organizations: Express Scripts operates various group purchasing organizations that negotiate pricing for the purchase of pharmaceuticals, fees and formulary rebates with pharmaceutical manufacturers on behalf of their participants. They also provide various administrative services to their participants including management and reporting.

Clinical Solutions: We offer innovative clinical programs to help our clients drive better health outcomes at a lower cost by identifying and addressing potentially unsafe or wasteful prescribing, dispensing and use of prescription drugs and communicating with, or supporting communications with, physicians, pharmacies and customers.

oOur Health Connect 360 SM offering is a transformational, outcomes based clinical management program that bridges pharmacy, medical, lab and patient engagement data to develop insights and deliver personalized health care interventions. Clinical outcomes and quality metrics are tailored to client needs and guaranteed.

oThrough the Express Scripts Digital Health FormularySM offering, we evaluate digital health solutions available on the market, providing a list to clients of solutions that provide clinical effectiveness, data security, user-friendly experience and financial value.

oAdvanced Utilization Management programs are the number-one tool for decreasing client spend on pharmacy. These include prior authorization, drug quantity management, step therapy and preferred specialty management.

oEnhanced Fraud, Waste & Abuse is an investigative service program that helps plan sponsors identify potential problem customers and prescribers with unusual or excessive utilization patterns. The program is designed to help identify outliers and situations of abnormal use or prescribing patterns by analyzing types of prescriptions, refill patterns and pharmacy utilization.


Other solutions include RationalMed®, ScreenRx®, ExpressAlliance®, Advanced Opioid Management®, and OnePASM offerings, as well as Medication Therapy and Medical Benefit Drug Management.

Value-Based Programs:

oSafeGuardRx®: We offer a solution platform aimed at therapy classes that pose significant budgetary threats and clinical challenges to patients. Our solutions are designed to keep our clients ahead of the cost curve while providing customers the personalized care and access they need. These solutions are offered throughout our pharmacy benefit management services and include, but are not limited to care for: cardiovascular, diabetes, hepatitis, inflammatory conditions, migraine, multiple sclerosis, oncology, pulmonary, and rare conditions. Innovative programs, such as our SafeGuardRx program, combine utilization management controls with formulary management, the specialized care model of our Therapeutic Resource Center® program and comprehensive guarantees, and help us to change the market in key categories. Through our Therapeutic Resource Center® offering, we provide caring for customers with the most complex and costly chronic conditions including cardiovascular disease, diabetes, cancer, HIV, asthma, depression and other rare and specialty conditions. These services optimize the safe and appropriate dispensing of therapeutic agents, minimize waste and improve clinical and financial outcomes. Through these services, specialist pharmacists provide the expert, personalized care that customers increasingly demand. Notably, our programs covering oncology and inflammatory conditions have introduced a value-based contracting approach with payments now tied to a product’s effectiveness.

oPatient Assurance ProgramSM: This program addresses the need for greater affordability and access to insulin by providing a fixed out-of-pocket cost to customers in non-government funded benefit plans.

oEmbarc Benefit ProtectionSM: This program combines health benefit management, health services and specialty pharmacy capabilities to make emerging gene therapy treatments more affordable for the payor, the employer and the patient.

Provider Services:  CuraScript SD is a specialty distributor of pharmaceuticals and medical supplies (including injectable and infusible pharmaceuticals and medications to treat specialty and rare or orphan diseases) directly to health care providers, clinics and hospitals in the United States for office or clinic administration. Through this business, we provide distribution services primarily to office and clinic-based physicians who treat customers with chronic diseases and regularly order costly specialty pharmaceuticals. This business provides competitive pricing on pharmaceuticals and medical supplies, operates three distribution centers and ships most products overnight within the United States; it also provides distribution capabilities to Puerto Rico and Guam. It is a contracted supplier with most major group purchasing organizations and leverages our distribution platform to operate as a third-party logistics provider for several pharmaceutical companies.

Health Benefit Management Services:  eviCore is a leading provider of integrated health benefit management solutions that focus on driving adherence to evidence-based guidelines, improving the quality of patient outcomes and reducing the cost of care for our clients. eviCore manages: diagnostic imaging, comprehensive musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy and medical oncology. eviCore contracts with health plans and other commercial and government payors to promote the appropriate use of health care services by the customers they serve. In certain instances, this occurs through capitated risk arrangements, when we assume the financial obligation for the cost of health care services provided to eligible customers covered by eviCore health care management programs.




Clients: We provide services to managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans, government health programs, providers, clinics, hospitals and others.

Patients: Prescription drugs are dispensed to patients connected to the service offerings we provide to clients. Prescription drugs are dispensed primarily through networks of retail pharmacies under non-exclusive contracts with us and through our home delivery and specialty drug fulfillment pharmacies.


The Department of Defense’s TRICARE® Pharmacy Program is the military health care program serving active-duty service customers, National Guard and Reserve customers and retirees, as well as their dependents. Under this contract, we provide online claims adjudication, home delivery services, specialty pharmacy clinical services, claims processing and contact center support and other services critical to managing pharmacy trend. In 2019, revenues from this contract were significant to the segment.


On January 30, 2019, Anthem, Inc. (“Anthem”) exercised its right to early termination of its pharmacy benefit management services agreement, effective March 1, 2019. As of December 31, 2019, the transition of customers is substantially complete. For further discussion of our Anthem relationship, see the “Executive Summary – Key Transactions and Business Developments” section of our MD&A located in Part II, Item 7 of the Form 10-K. In 2019, Anthem revenues were significant to the segment.


In December 2019, Express Scripts and Prime Therapeutics LLC (“Prime”) announced a three-year agreement designed to deliver care for Prime’s clients and their patients by enhancing pharmacy networks and pharmaceutical manufacturer value.





The health care industry has undergone periods of substantial consolidation and may continue to consolidate in the future. We believe the primary competitive factors in the industry include the ability to: negotiate with retail pharmacies to ensure our retail pharmacy networks meet the needs of our clients and customers; provide home delivery and specialty pharmacy services; negotiate discounts and rebates on prescription drugs with drug manufacturers; navigate the complexities of government-reimbursed business including Medicare, Medicaid and the public exchanges; manage cost and quality of specialty drugs; use the information we obtain about drug utilization patterns and consumer behavior to reduce costs for our clients and customers and the level of service we provide.


Managed Care PBMs: CVS Caremark (owned by CVS Health Corporation), Envision Rx (owned by Rite Aid Corporation), Humana, IngenioRx (owned by Anthem), Optum (owned by UnitedHealth Group Inc.) and Prime Therapeutics (owned by a collection of Blue Cross / Blue Shield Plans) compete with us on a variety of products and in various regions throughout the United States.

Independent PBMs: MedImpact and Navitus Health Solutions compete with us on a variety of products and in various regions throughout the United States.

Retail Pharmacies: CVS Caremark, Walgreens Boots Alliance, Inc. and WalMart, Inc.

Third-Party Benefits Administrators: Third parties that specialize in claim adjudication and benefit administration, such as Argus, are direct competitors. With the emergence of alternative benefit models through Private Exchanges, the competitive landscape also includes brokers, health plans and consultants. Some of these competitors may deploy greater financial, marketing and technological resources than we do and new market entrants, including strategic alliances aimed at modifying the current health care delivery models or entering the prescription drug sector from another sector of the health care industry, may increase competition as barriers to entry are relatively low.

Clinical Solutions and Health Care Data Analytics Companies: OptumRx (owned by UnitedHealth Group Inc.), Anthem, Magellan Health, HealthHelp, Cotiviti, and Inovalon are among the companies that compete with us in this market.




Sales and Account Management: Our sales and account management teams market and sell pharmacy benefit management solutions and are supported by client service representatives, clinical pharmacy managers and benefit analysis consultants. These teams work with clients to develop innovative strategies that put medicine within reach of customers while helping health benefit providers improve access to and affordability of prescription drugs.

Supply Chain: Our supply chain contracting and strategy teams negotiate and manage pharmacy network contracts, pharmaceutical and wholesaler purchasing contracts and manufacturer rebate contracts. As our clients continue to experience increased cost trends, our supply chain teams develop innovative solutions such as our SafeGuardRx program and narrow networks to combat these cost increases. In addition, our Formulary Consulting team, consisting of pharmacists and financial analysts, provides services to our clients to support formulary decisions, benefit design consultation and utilization management programs.

Clinical Support: Our staff of highly trained health care professionals provides clinical support for our pharmacy benefit management and health benefit management services, including more specialized care for customers with select chronic and complex conditions. We operate condition-specific Therapeutic Resource Center facilities staffed with specialist pharmacists, nurses and other clinicians who provide personal and specialized customer care. Our clinical solutions staff of pharmacists and physicians provides clinical development and operational support for our pharmacy benefit management services. These health care providers conduct a wide range of activities including identifying emerging medication-related safety issues and alerting physicians, clients, and customers (as appropriate); providing drug information services; managing formulary; and developing utilization management, safety (drug utilization review) and other clinical interventions.




We maintain an inventory of brand-name and generic pharmaceuticals in our home delivery and specialty pharmacies. Our specialty pharmacies also carry biopharmaceutical products to meet the needs of our customers, including pharmaceuticals for the treatment of rare or chronic diseases; if a drug is not in our inventory, we can generally obtain it from a supplier within one business day.


We purchase pharmaceuticals either directly from manufacturers or through authorized wholesalers. Health Services uses one wholesaler more than others in the industry, but holds contracts with other wholesalers if needs for an alternate source arise. Generic pharmaceuticals are generally purchased directly from manufacturers.



Industry Developments


See the “Industry Developments” section of the MD&A in this Form 10-K for discussion of key industry developments impacting this segment.


Intellectual Property Rights




We also hold a portfolio of patents and pending patent applications. We are not substantially dependent on any single patent or group of related patents.





Integrated Medical consists of a Commercial operating segment that includes our employer-sponsored medical coverage and a Government operating segment that includes Medicare offerings for seniors and individual insurance offerings both on and off the public health insurance exchanges. In 2019, Integrated Medical reported adjusted revenues of $36.5 billion and pre-tax adjusted income from operations of $3.8 billion.



Broad and deep portfolio of solutions across Commercial and Government operating segments

Commitment to highest-quality health outcomes and customer experiences

Collaborative physician engagement models emphasizing value over volume of services

Integrated benefit solutions that deliver value for our customers, clients and partners

Technology and data analytics powering actionable insights and affordable, predictable solutions

Talented and caring people embracing change and putting customers at the center of all we do


We differentiate ourselves by providing innovative, personalized, and affordable health care benefit solutions based on the unique needs of the individuals and clients we serve. We increase value through our integrated approach and use of technology and data analytics to enhance patient engagement and health care outcomes, underscoring our strategic focus on delivering an industry-leading customer experience. We continue to strengthen our collaborative relationships with providers as we accelerate our transition to a value-based reimbursement system.


We offer a mix of core health insurance products and services to employers, other groups and individuals along with specialty products and services designed to improve the quality of care, lower cost and help customers achieve better health outcomes. Many of these products are available on a standalone basis, but we believe they create additional value when integrated with a Cigna-administered health plan. Our products are available through several distribution channels including brokers, direct sales and public and private exchanges. Our three funding solutions (i.e., insured – experience-rated (“ER”), insured – guaranteed cost (“GC”), and administrative services only (“ASO”) arrangements) enable us to customize the amount of risk taken by, and lower costs for, our customers and clients.



The following chart depicts a high-level summary of our principal products and services in this segment, with definitions on subsequent pages.


Principal Products & Services

Major Brand(s)


Funding Solution(s)

Market Segment(s)

Primary Distribution Channel(s)

Primary Competitors

Commercial Medical

Managed Care

Cigna HealthCare




Brokers, Private Exchanges, Direct

National Insurers, Local Healthplans, Third-Party Administrators (“TPAs”)

Preferred Provider Organization (“PPO”)



National Insurers, TPAs




National Insurers, Local Health Maintenance Organizations (“HMOs”)

Government Medical

Individual and Family Plans

Cigna Connect

9 states(1)



Public and Private Exchanges

Local Healthplans, Start-ups, National Insurers

Medicare Advantage


16 states(2) & District of Columbia



Direct, Brokers

National Insurers, Local Healthplans

Medicare Stand –Alone PDPs

Cigna, Express Scripts




Direct, Brokers

National Insurers

Medicare Supplement


48 states(3) & District of Columbia



Brokers, Direct, Private Exchanges

National Insurers

Specialty Products and Services







Brokers, Direct

National Insurers, Specialty Companies







National Insurers, Specialty Companies

Consumer Health Engagement




Commercial, Government

Brokers, Direct

National Insurers, Specialty Companies

Pharmacy Management




Commercial, Government

Brokers, Direct

National PBMs

Behavioral Health

Cigna Behavioral Health




Brokers, Direct

National Insurers, Specialty Companies


Cigna Dental HealthCare



Commercial, Government

Brokers, Direct

Dental Insurers, National Insurers

(1)AZ, CO, FL, IL, MO, NC, TN, TX, VA

(2)AL, AZ, AR, DE, FL, GA, IL, KS, MD, MS, MO, NC, PA, SC, TN, TX

(3)All states except MA and NY


Principal Products & Services


Commercial Medical


Managed Care Plans are offered through our insurance companies, HMOs and TPA companies. HMO, LocalPlus®, Network Open Access and Open Access Plus plans use meaningful cost-sharing incentives to encourage the use of “in-network” versus “out-of-network” health care providers. The national provider network for Managed Care Plans is somewhat smaller than the national network used with the PPO plan product line.

PPO Plans feature a network with broader provider access than the Managed Care Plans.

Consumer-Driven Products are typically paired with a high-deductible medical plan and offer customers a tax-advantaged way to pay for eligible health care expenses. These products, consisting of health savings accounts, health reimbursement accounts and flexible spending accounts, encourage customers to play an active role in managing their health and health care costs.


Government Medical


Individual and Family Plans feature an insurance policy coupled with a network of health care providers in a geographic area who have been selected with cost and quality in mind.

Medicare Advantage Plans allow Medicare-eligible beneficiaries to receive health care benefits, including prescription drugs, through a managed care health plan such as our coordinated care plans. Our Medicare Advantage Plans are primarily HMO plans marketed to individuals. A significant portion of our Medicare Advantage customers receive medical care from our value-based models that focus on developing highly engaged physician networks, aligning payment incentives to improved health outcomes and using timely and transparent data sharing.

Medicare Stand-Alone Prescription Drug Products provide a number of prescription drug plan options, as well as service and information support, to Medicare and Medicaid eligible customers. Our stand-alone plans offer the savings of Medicare combined with the flexibility to provide enhanced benefits and a drug list tailored to an individual’s specific needs. Eligible beneficiaries benefit from broad network access and value-added services intended to promote wellness and affordability for our eligible beneficiaries.

Medicare Supplement Plans provide Medicare-eligible beneficiaries with federally standardized Medigap-style plans. Beneficiaries may select among the various plans with specific plan options to meet their unique needs and may visit, without the need for a referral, any health care provider or facility that accepts Medicare throughout the United States.


Specialty Products and Services

Stop-Loss insurance coverage is offered to self-insured clients whose group health plans are administered by Cigna. Stop-loss insurance provides reimbursement for claims in excess of a predetermined amount for individuals, the entire group, or both.

Cost-Containment Programs are designed to contain the cost of covered health care services and supplies. These programs reduce out-of-network utilization and costs, protect customers from balance billing and educate customers regarding the availability of lower cost in-network services. In addition, under these programs we negotiate discounts with out-of-network providers, review provider bills and recover overpayments. We charge fees for providing or arranging for these services. These programs may be administered by third-party vendors that have contracted with Cigna.

Consumer Health Engagement services are offered to customers covered under plans administered by Cigna or by third-party administrators. These services consist of an array of health management, disease management and wellness services. Our Medical Management programs include case, specialty and utilization management and a Health Information line. Our Health Advocacy program services include early intervention in the treatment of chronic conditions and an array of health and wellness coaching. Additionally, we administer incentives programs designed to encourage customers to engage in health improvement activities.

Pharmacy Management services and benefits can be combined with our medical offerings. The comprehensive suite of pharmacy management services available to clients and customers includes benefits management, specialty pharmacy services, clinical solutions, home delivery and certain health management services.

Behavioral Health services consist of behavioral health care case management, employee assistance programs (“EAP”) and work/life programs. We focus on integrating our programs and services with medical, pharmacy and disability programs to facilitate customized, holistic care.


Dental solutions include dental health maintenance organization plans, dental preferred provider organization plans, exclusive dental provider organization plans, traditional dental indemnity plans and a dental discount program. Employers and other groups can purchase our products on either an insured or self-insured basis as standalone products or in conjunction with medical products. Additionally, individual customers can purchase insured dental preferred provider organization plans as standalone products or in conjunction with individual medical policies.


Funding Solutions


ASO. Plan sponsors (i.e., employers, unions and other groups) self-fund all claims, but may purchase stop-loss insurance to limit exposure. We collect fees from plan sponsors for providing access to our participating provider network and for other services and programs including: claims administration; behavioral health services; disease management; utilization management; cost containment; dental and pharmacy benefit management. Approximately 85% of our commercial medical customers are in ASO arrangements.

Experience-rated Insurance. Premium rates are established at the beginning of a policy period and are typically based on prior claim experience of the policyholder. When claims and expenses are less than the premium charged (an “experience surplus” or “margin”), the policyholder may be credited for a portion of this experience surplus or margin. If claims and expenses exceed the premium charged (an “experience deficit”), we bear these costs. In certain cases, experience deficits incurred while the policy is in effect are accumulated and may be recovered through future policy year experience surpluses or margins. Approximately 6% of commercial medical customers are in experience-rated arrangements.

Guaranteed Cost Insurance. Premium rates are established at the beginning of a policy period and, depending on group size, may be based in whole or in part on prior experience of the policyholder or on a pool of similar policyholders. We generally cannot subsequently adjust premiums to reflect actual claim experience until the next annual renewal. The policyholder does not participate, or share in, actual claim experience. We keep any experience surplus or margin if costs are less than the premium charged (subject to minimum medical loss ratio rebate requirements discussed below) and bear the risk for actual costs in excess of the premium charged. Approximately 9% of commercial medical customers are in guaranteed cost arrangements.


In most states, individual and group insurance premium rates must be approved by the applicable state regulatory agency (typically department of insurance) and state or federal laws may restrict or limit the use of rating methods. Premium rates for groups and individuals are subject to state review to determine whether they are adequate, not excessive and not unfairly discriminatory. In addition, the Patient Protection and Affordable Care Act (“ACA”) subjects individual and small group policy rate increases above an identified threshold to review by the United States Department of Health and Human Services (“HHS”) and requires payment of premium refunds on individual and group medical insurance products if minimum medical loss ratio (“MLR”) requirements are not met. The MLR represents the percentage of premiums used to pay medical claims and expenses for activities that improve the quality of care. In our individual business, premiums may also be adjusted as a result of the government risk adjustment program that accounts for the relative health status of our customers. See the “Business - Regulation” section of this Form 10-K for additional information about commercial MLR requirements and risk mitigation programs of the ACA.


Market Segments


Commercial comprises employers from the following market segments:

oNational. Multistate employers with 5,000 or more U.S.-based, full-time employees. We offer primarily ASO funding solutions in this market segment.

oMiddle Market. Employers generally with 500 to 4,999 U.S.-based, full-time employees. This segment also includes single-site employers with more than 5,000 employees and Taft-Hartley plans and other groups. We offer ASO, experience-rated and guaranteed cost insured funding solutions in this market segment.

oSelect. Employers generally with 51-499 eligible employees. We usually offer ASO with stop-loss insurance coverage and guaranteed cost insured funding solutions in this market segment.

oSmall Group Employers generally with 2-50 eligible employees. Pending regulatory approvals, we expect to launch a small group offering in select markets in 2020 with a strategic partner.

Individual. Consistent with the regulations for Individual ACA compliant plans, we offer only guaranteed cost plans in this market segment.

Government includes individuals who are Medicare-eligible beneficiaries, as well as employer group sponsored pre- and post-65 retirees. We also have dual-eligible customers who receive both Medicare and Medicaid benefits. We receive revenue from the Centers for Medicare and Medicaid Services (“CMS”) based on customer demographic data and health risk factors. In 2019, revenues from CMS were significant to the segment.



Primary Distribution Channels


Brokers. Sales representatives distribute our products and services to a broad group of insurance brokers and consultants across the United States.

Direct. Cigna sales representatives distribute our products and services directly to employers, unions and other groups or individuals across the United States. Various products may also be sold directly to insurance companies, HMOs and third-party administrators. This may take the form of in-person contact, telephone or group selling venues.

Private Exchanges. We partner with select companies that have created private exchanges where individuals and organizations can acquire health insurance. We actively evaluate private exchange participation opportunities as they emerge in the market and target our participation to those models that best align with our mission and value proposition.

Public Exchanges. Public health insurance exchanges for ACA compliant plans on which Cigna may offer individual policies.




The primary competitive factors affecting our business are quality and cost effectiveness of service and provider networks; effectiveness of medical care management; products that meet the needs of employers and their employees; total cost management; technology; and effectiveness of marketing and sales. Financial strength, as indicated by ratings issued by nationally recognized rating agencies, is also a competitive factor. Our health advocacy capabilities, holistic approach to consumer engagement, breadth of product offerings, clinical care and health management capabilities and array of product funding options are competitive advantages. We believe our focus on improving the health, well-being and peace of mind of those we serve, and how we deliver better affordability, predictability and simplicity in health care will allow us to further differentiate ourselves.

National Insurers. United HealthGroup Inc., Aetna Inc. (owned by CVS Health Corporation), Anthem, Humana and Blue Cross Blue Shield plans compete with us in a variety of products and regions throughout the United States.

Local Healthplans. Blue Cross Blue Shield plans, local affiliates of major insurance companies and hospitals and regional stand-alone managed care and specialty companies compete with us in the states in which we offer managed care products. Additionally, plan sponsors may contract directly with providers.

TPAs. Third-party administrators compete with us for ASO business.

Start-ups. Emerging participants including alternative health service models, consortiums and other health plans seeking to disrupt, often through competitive technology.

Dental Insurers. Various companies offering primarily dental insurance compete with us on these products.

Specialty Companies. Specialty insurance or service companies that offer niche products and services compete with us.


Partnering to Deliver on the Promise of More Affordable, Predictable, Simple Health Care


Cigna’s Connected Care strategy engages customers in their health, collaborates with providers to help them improve their performance, and connects customers and providers through aligned health goals, incentives and actionable information to enable better decisions and outcomes. Our delivery strategy is designed to ensure our customers have access to the right care and in the preferred and appropriate setting at the right time. Fueled by advanced insights and predictive analytics, Cigna is committed to developing innovative solutions that span the health care delivery system and can be applied to different types of providers. Currently we have numerous collaborative arrangements with our participating health care providers that reach 3.9 million customers and are actively developing new arrangements to support our Connected Care strategy.


Accountable Care Program. We have 257 collaborative care arrangements with primary care groups built on the patient-centered medical home and accountable care organization (“ACO”) models. Our arrangements span more than 34 states and reach over 3 million customers. We are committed to increasing the number of groups over the next several years, as well as deepening existing relationships, with a goal of reaching over 270 programs by the end of 2020.

Hospital Quality Program. We have contracts with over 500 hospitals with reimbursements tied to quality metrics. We expect to grow this number to over 600 hospitals by the end of 2020.

Specialist Programs. We have 290 arrangements with specialist groups in value-based reimbursement arrangements. Our goal is to reach approximately 380 arrangements by the end of 2020. Programs include nationwide arrangements with several types of specialist groups including orthopedics, obstetrics and gynecology, cardiology, gastroenterology, oncology, nephrology and neurology. Arrangements include care coordination and episodes of care reimbursements for meeting cost and quality goals.

Independent Practice Associations. We have value-based physician engagement models in our Medicare Advantage business that allow physician groups to share financial outcomes with us. This clinical model also includes outreach to new and at-risk patients to ensure they are accessing their primary care physician.


Participating Provider Network. We provide our customers with an extensive network of participating health care providers, hospitals and other facilities, pharmacies and providers of health care services and supplies. In most instances, we contract with them directly; however, in some instances, we contract with third parties for access to their provider networks and care management services. In addition, we have entered into strategic alliances with several regional managed care organizations (e.g., Tufts Health Plan, HealthPartners, Inc., Health Alliance Plan and MVP Health Plan) to gain access to their provider networks and discounts.





Cigna’s International Markets segment has operations in over 30 countries or jurisdictions providing a full range of comprehensive medical and supplemental health, life, and accident benefits to individuals and employers. Products and services include comprehensive health coverage, hospitalization, dental, critical illness, personal accident, term life, and variable universal life. In 2019, International Markets reported adjusted revenues of $5.6 billion and pre-tax adjusted income from operations of $762 million.




Offering a broad range of health and protection-related solutions to meet the needs of the growing middle class and globally mobile

Leveraging deep consumer insights to drive product and service innovation

Maintaining leading innovative, direct-to-consumer distribution capabilities

Providing access to quality, affordable care through one of the largest global provider networks

Implementing locally-licensed and compliant solutions managed by strong, locally-developed talent



Demand for our products and services is driven by the growing global middle class, aging populations, increasing prevalence of chronic conditions and rising global health care costs. Our focus on product and service innovation means we continue to deliver solutions that meet the evolving needs of individual and group customers. Our products, distribution channels and funding sources range by customer and geography.



International Markets is well positioned to address the growing demand for access to quality, affordable care and supplemental health and life protection that fill gaps in public and private care. We distinguish ourselves through differentiated direct-to-consumer distribution, customer insights, product innovation, a leading provider network and compliant solutions. We identify and pursue attractive market opportunities to bring health and protection solutions and tailor those solutions to the market and customer needs. Over the past several years, we have extended our product offerings and geographic reach. The chart below provides a high-level summary of our principal products and services in this segment with definitions on subsequent pages.


Principal Products & Services

Major Brand(s)


Funding Solution(s)

Key Relationships

Primary Distribution Channel(s)

Primary Competitors

Global Health Care

Cigna Global Health Benefits

Cigna Global IPMI

Worldwide (except as limited by applicable law)


Multinational Companies, Inter-governmental and Non-governmental Organizations

Globally mobile individuals

Brokers, Agents, Direct-to-Consumer

Global insurers

Local Health Care






United Kingdom, Spain, Hong Kong, India, China, Singapore


Employer Groups



Brokers, Agents, Direct-to-Consumer

Global insurers and local non-U.S. insurers

Supplemental Health, Life, & Accident


LINA Korea






Asia Pacific, India, Turkey



Affinity, Bancassurance, Brokers, Agents, Direct-to-Consumer

Global insurers and local non-U.S. insurers


Principal Products & Services


Global Health Care products and services include insurance and administrative services for medical, dental, pharmacy, vision and life, accidental death and dismemberment and disability risks. We are leading providers of products and services that meet the needs of multinational employers, intergovernmental and nongovernmental organizations and globally mobile individuals with a focus on keeping employees healthy and productive. The employer benefits products and services are offered through guaranteed cost, experience-rated and administrative services only funding solutions, while individuals purchase guaranteed cost coverage. For definitions of funding solutions, see “Funding Solutions” in the “Integrated Medical” description of business section of this Form 10-K.


Local Health Care products and services include medical, dental, pharmacy and vision as well as life coverage. The customers of local health care businesses are employers and individuals located in specific countries where the products and services are purchased. These employer services can similarly be funded through a range of options; individuals purchase on a guaranteed cost basis.


Supplemental Health, Life and Accident Insurance products and services generally provide simple, affordable coverage of risks for the health and financial security of individuals. Supplemental health products provide stated benefit payments for certain specified health risks and include personal accident, accidental death, critical illness, hospitalization, travel, dental, dementia, cancer and other dread disease coverages. We also offer customers term and variable universal life insurance and certain savings products in select markets.





We anticipate that the competitive environment will intensify as insurance and financial services providers more aggressively pursue expansion opportunities across geographies, particularly Asia. We believe competitive factors will include speed-to-market, customer insights, branding, product, distribution and service innovation, underwriting and pricing, efficient management of marketing and operating processes, commission levels paid to distribution partners, the quality of compliance functions, claims, network coverage and medical cost management, and talent acquisition and retention. Additionally, in most overseas markets, perception of commitment to the market and financial strength will likely be an important competitive factor.


Pricing and Reinsurance


Premium rates and fees for our global and local health care products reflect assumptions about future claims, expenses, customer demographics, investment returns and profit margins. For products using networks of contracted health care providers and facilities, premiums reflect assumptions about the impact of these contracts and utilization management on future claims. Most contracts permit rate changes at least annually.


The profitability of health care products is dependent upon the accuracy of projections for health care inflation (unit cost, location of delivery of care, currency of incurral and utilization), customer demographics, the adequacy of fees charged for administration and effective medical cost management.


Premium rates for our supplemental benefits products are based on assumptions about mortality, morbidity, customer acquisition and retention, customer demographics, expenses and capital requirements, as well as interest rates. Variable universal life insurance products fees consist of mortality, administrative, asset management and surrender charges assessed against the contractholder’s fund balance. Mortality charges on variable universal life may be adjusted prospectively to reflect expected mortality experience. Most contracts permit premium rate changes at least annually.


A global approach to underwriting risk management allows each local business to underwrite and accept risk within specified limits. Retentions are centrally managed through cost-effective use of external reinsurance to limit our liability on per life, per risk and per event (catastrophe) bases.


Industry Developments and Other Items Affecting International Markets


South Korea represents our single largest geographic market for International Markets. For information on this concentration of risk for the International Markets segment's business in South Korea, see "Other Items Affecting Results of International Markets" in the International Markets section of the MD&A of this Form 10-K.


Pressure on social health care systems, a rapidly aging population and increased wealth and education in developing insurance markets are leading to higher demand for health insurance and financial security products. In the supplemental health, life and accident business, direct marketing channels continue to grow and attract new competitors with industry consolidation among financial institutions and other affinity partners.


Data privacy regulation has tightened in all markets in the wake of high-profile data privacy incidents, impacting affinity partner and customer attitudes toward direct marketing of insurance and other financial services. It has also placed an added emphasis on the importance of operational compliance.





As explained further in the introduction to this Form 10-K, Group Disability and Other consists of our Group Disability and Life operating segment, along with COLI and certain run-off businesses reported together in Other Operations. In 2019, Group Disability and Other reported adjusted revenues of $5.2 billion and pre-tax adjusted income from operations of $501 million.


In December 2019, Cigna entered into a definitive agreement to sell the Group Disability and Life business to New York Life Insurance Company for $6.3 billion. The sale is expected to close in the third quarter of 2020 subject to applicable regulatory approvals and other customary closing conditions. Until the transaction is finalized, we continue to operate our business as usual and serve our customers.



Disability absence management model that reduces overall costs to employers

Integration of disability products with medical and specialty offerings, promoting health and wellness and optimizing employee productivity

Complementary portfolio of group disability, life and accident offerings

Disciplined underwriting, pricing and investment strategies supporting profitable long-term growth


Group Disability and Life


Our Group Disability and Life operating segment includes our commercial long- and short-term disability products and our term life group insurance products. We also offer personal accident insurance and voluntary products and services. These products and services are distributed through brokers and direct sales and are available in guaranteed cost, experience-rated and ASO arrangements. The following chart depicts a high-level summary of our Principal Products and Services in this segment with definitions on subsequent pages.


Principal Products & Services


Premium Rates

Funding Solution(s)

Market Segment(s)

Primary Distribution Channel(s)

Primary Competitors

Group Disability

Long-term Disability

Employer, Employee

Preset, guaranteed



Brokers, Direct

National Insurers, Regional Insurers

Short-term Disability

Employer, Employee

Preset, guaranteed